naccme1000trueCVLN ACC Newsletter/2012-03-26T14:03:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDCVLN ACC Newsletter/Heart_coronary_artery_lesion.jpg2012-03-26T14:06:29.000Z"9b73a52a4049ee23b58f42ca022d0242"301687STANDARDCVLN ACC Newsletter/Heart_coronary_territories.jpg2012-03-26T17:17:50.000Z"228b08718cb453d273c217fe09204242"229329STANDARDCVLN ACC Newsletter/Hk_ventricle_bionerd.jpg2012-03-26T17:17:49.000Z"939fa3fb76baf0aa2174813b4f290db8"34365STANDARDCVLN ACC Newsletter/Myocardial Infarction.jpg2012-03-26T14:06:33.000Z"eb905f07aac35d25dd589ae17cffebe8"119145STANDARDCVLN ACC Newsletter/Reopro.jpg2012-03-26T14:06:34.000Z"31f1ff22240970f3f176b0a35ab19aa9"86660STANDARDCVLN ACC Newsletter/Screen Shot 2012-03-26 at 10.06.05 AM.png2012-03-26T14:06:35.000Z"03e463808592c8f2626b89a2a08f7298"290727STANDARDCVLN ACC Newsletter/Screen Shot 2012-03-26 at 11.12.48 AM.png2012-03-26T15:13:14.000Z"274870ab10ae425eb010327fe46a1a46"281191STANDARDFooter700x120.jpg2012-05-03T20:21:23.000Z"4383d6fd365908cf1d6ebdb9a83c39c5"57608STANDARDNACCME Vids.rar2011-09-24T18:53:11.000Z"e0d87b5e372a7e090e83eea88edb4bba-204"1068784747STANDARDNACCME Vids/2011-09-24T18:59:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-336-3/2011-09-24T18:59:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-336-3/email_archive/2011-09-24T18:59:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-347/2011-09-24T18:59:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-349-2n/2011-09-24T18:59:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-349n/2011-09-24T18:59:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-350-2/2011-09-24T18:59:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-350-2n/2011-09-24T18:59:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-350n/2011-09-24T18:59:30.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-356/2011-09-24T18:59:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-356/slides/2011-09-24T18:59:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-359-3/2011-09-24T18:59:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-359-3/webcast/2011-09-24T18:59:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-363n/2011-09-24T18:59:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-369-3/2011-09-24T18:59:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-369/2011-09-24T18:59:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-370-7/2011-09-24T18:59:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-371/2011-09-24T19:00:13.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-371/slides/2011-09-24T19:00:13.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-372-2/2011-09-24T19:00:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-372-2/_notes/2011-09-24T19:00:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-372/2011-09-24T19:00:20.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-373-2/2011-09-24T19:00:22.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-373-3/2011-09-24T19:00:22.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-373-3/archive/2011-09-24T19:00:22.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-373/2011-09-24T19:00:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-374-2/2011-09-24T19:00:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-374-3/2011-09-24T19:00:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-374-6/2011-09-24T19:00:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-374/2011-09-24T19:00:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-375n/2011-09-24T19:00:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-376-2/2011-09-24T19:00:32.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-376-2/2010-412-1/2011-09-24T19:00:32.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-376-3/2011-09-24T19:00:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-376/2011-09-24T19:00:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-376/slides/2011-09-24T19:00:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-377-2n/2011-09-24T19:00:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-377n/2011-09-24T19:00:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-379/2011-09-24T19:00:34.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-380/2011-09-24T19:00:34.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-381-2/2011-09-24T19:00:43.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-381/2011-09-24T19:00:34.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-381/slides/2011-09-24T19:00:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-382-1/2011-09-24T19:00:43.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-382-1/slides/2011-09-24T19:00:43.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-382-2/2011-09-24T19:00:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-383-3/2011-09-24T19:00:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-384/2011-09-24T19:00:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-384/slides/2011-09-24T19:00:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-385-2/2011-09-24T19:01:06.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-385/2011-09-24T19:00:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-385/slides/2011-09-24T19:00:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-386-2n/2011-09-24T19:01:07.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-386n/2011-09-24T19:01:07.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-387-3/2011-09-24T19:01:07.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-387-4/2011-09-24T19:01:11.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-387-6/2011-09-24T19:01:11.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-389/2011-09-24T19:01:40.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-389/slides/2011-09-24T19:01:40.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-390/2011-09-24T19:01:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-391n/2011-09-24T19:01:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-392n/2011-09-24T19:01:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-393-1/2011-09-24T19:01:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-393-2/2011-09-24T19:01:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-394-2n/2011-09-24T19:01:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-394/2011-09-24T19:01:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-394n/2011-09-24T19:01:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-395-2/2011-09-24T19:02:10.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-395/2011-09-24T19:01:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-395/slides/2011-09-24T19:02:00.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-396-1n/2011-09-24T19:02:12.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-397n/2011-09-24T19:02:13.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-398-2/2011-09-24T19:02:13.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-399-1/2011-09-24T19:02:45.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-401-1/2011-09-24T19:03:06.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-401-1/ondemand/2011-09-24T19:03:07.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-401-2/2011-09-24T19:03:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-402-1/2011-09-24T19:03:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-402/2011-09-24T19:03:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-403-1/2011-09-24T19:03:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-403-1/archive/2011-09-24T19:03:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-405/2011-09-24T19:04:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-405/archive/2011-09-24T19:04:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-406-1/2011-09-24T19:04:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-411/2011-09-24T19:04:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-412-1/2011-09-24T19:04:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-412-1/archive/2011-09-24T19:04:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-413/2011-09-24T19:04:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-413/archive/2011-09-24T19:04:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-416/2011-09-24T19:05:14.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-416/archive/2011-09-24T19:05:15.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-417/2011-09-24T19:05:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-417/archive/2011-09-24T19:05:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-418/2011-09-24T19:06:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2010-418/archive/2011-09-24T19:06:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-400-9/2011-09-24T19:06:43.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-12/2011-09-24T19:06:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-12/webcast/2011-09-24T19:06:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-2/2011-09-24T19:08:01.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-2/archive/2011-09-24T19:08:01.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-4/2011-09-24T19:08:16.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-5/2011-09-24T19:08:19.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-404-5/archive/2011-09-24T19:08:19.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-406-2/2011-09-24T19:08:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-406-2/archive/2011-09-24T19:08:33.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-406-3/2011-09-24T19:08:34.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-407-3/2011-09-24T19:08:39.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-407-3/email/2011-09-24T19:08:39.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-407-4/2011-09-24T19:08:39.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-408-2/2011-09-24T19:08:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-408-2/archive/2011-09-24T19:08:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-410-3/2011-09-24T19:09:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-415/2011-09-24T19:09:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-419-2/2011-09-24T19:09:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-422/2011-09-24T19:09:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-423-3/2011-09-24T19:09:30.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-423-3/cases/2011-09-24T19:09:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-423-3a/2011-09-24T19:09:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-423-3c/2011-09-24T19:09:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-425-1/2011-09-24T19:09:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-425-1/archive/2011-09-24T19:09:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-428-2/2011-09-24T19:10:04.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-429/2011-09-24T19:10:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-429/archive/2011-09-24T19:10:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-429/archive/v2/2011-09-24T19:10:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-430/2011-09-24T19:10:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-431/2011-09-24T19:10:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-431/round2/2011-09-24T19:10:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-432-2/2011-09-24T19:10:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-433/2011-09-24T19:10:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-434/2011-09-24T19:10:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-434/archive/2011-09-24T19:10:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-436/2011-10-08T18:08:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-436/STJude_logo.jpg2011-10-08T18:21:49.000Z"0f84ed9465c290fad196b26ae55af060"14405STANDARDNACCME Vids/2011-436/archive/2011-10-08T18:08:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies.js2011-10-08T18:08:28.000Z"15df1fc0d86d57d4c91ed13edf4905a2"514STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies.mp42011-10-08T18:08:28.000Z"5f23db3bae9fc28abedb397b9494c55d"556115055STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies_config.xml2011-10-08T18:08:26.000Z"26f560357bff807289d83ef50ca3bb9d"7940STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies_controller.swf2011-10-08T18:08:26.000Z"c0d86be66ee725799be6ea4a7bacbdfa"189057STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies_nofp_bg.gif2011-10-08T18:08:27.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDNACCME Vids/2011-436/archive/Debating Clinical Controversies_preload.swf2011-10-08T18:08:27.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDNACCME Vids/2011-436/archive/Debating_Clinical_Controversies.html2011-10-08T18:21:48.000Z"bda4ddd7717d76170f2763d86b909dcb"3811STANDARDNACCME Vids/2011-436/archive/ProductionInfo.xml2011-10-08T18:21:48.000Z"b74644d357f2db6b6fd0ea886c7b5d17"14494STANDARDNACCME Vids/2011-436/archive/hrs_webcast_screen.jpg2011-10-08T18:21:48.000Z"0b2ff26c1796032d0e3ad4f9157c62cf"73942STANDARDNACCME Vids/2011-436/archive/swfobject.js2011-10-08T18:21:48.000Z"eaa5417940c71f441b016b12c534665d"9759STANDARDNACCME Vids/2011-436/banner.jpg2011-10-08T18:21:49.000Z"a8052fdec9586f063bb40c96f0f92f21"44014STANDARDNACCME Vids/2011-436/evite_cover.jpg2011-10-08T18:21:49.000Z"add05138c3b5a54c5b3e84b44fd1c024"43823STANDARDNACCME Vids/2011-436/fm_cover.jpg2011-10-08T18:21:49.000Z"567e679d2cbbab3b6434c707d142c9cb"18594STANDARDNACCME Vids/2011-437-1/2011-09-24T19:11:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-437-2/2011-09-24T19:11:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-438-1/2011-09-24T19:11:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-438-2/2011-09-24T19:11:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-439/2011-09-24T19:11:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-439/archive/2011-09-24T19:11:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-439/case_vignettes/2011-09-24T19:11:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-440-1/2011-09-24T19:11:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-441/2011-09-24T19:12:00.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-441/archive/2011-09-24T19:12:00.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-442-1/2011-09-24T19:12:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-442-2/2011-09-24T19:12:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-442/2011-09-24T19:12:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-443-1/2011-09-24T19:12:22.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-443-2/2011-09-24T19:12:40.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-445/2011-09-24T19:12:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-446/2011-09-24T19:12:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-447/2011-09-24T19:12:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-450-1/2011-09-24T19:12:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-451-1/2011-09-24T19:12:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-454/2011-09-24T19:12:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-457-1/2011-09-24T19:12:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-459/2011-09-24T19:12:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNACCME Vids/2011-460-1/2011-09-24T19:12:59.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/2011-11-08T18:49:21.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/2012_Phila_PDFS/2012-04-04T20:00:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/2012_Phila_PDFS/EvolvingTreatmentStrategiesSpectrumofBreastCancer.pdf2012-04-04T20:02:40.000Z"68dcbc4dee0aabf4282cbf692df80217"1913648STANDARDPLN/2012_Phila_PDFS/HyponatremiaInHospitalizedPatients.pdf2012-04-04T20:03:03.000Z"1777b57b4ca4dae03fc8c27e92ec30b7"1943600STANDARDPLN/2012_Phila_PDFS/ImprovingTheContinuityofDiabetesCare.pdf2012-04-04T20:03:24.000Z"dc667fa8af47eb669e9616a1377e9b69"3065101STANDARDPLN/2012_Phila_PDFS/MinimzingtheClinicalandCostBurdenofCDifficile.pdf2012-04-04T20:03:51.000Z"cf4ee86fcff7ea7dc88e067164059e39"1821914STANDARDPLN/2012_Phila_PDFS/NavigatingTheEvolvoingIronDeficiencyLandscake.pdf2012-04-04T20:04:07.000Z"2343665cffba82fead90240cbb8827e5"2415347STANDARDPLN/2012_Phila_PDFS/NewFrontiersTreatmentNonSmallCellLungCancer.pdf2012-04-04T20:04:28.000Z"ebe564b2597cd1636108b12b8be927f9"3856675STANDARDPLN/2012_Phila_PDFS/OpthalmologyInFocus.pdf2012-04-04T20:04:58.000Z"20663e1a5ed9658908b11a60c6d06d07"2396781STANDARDPLN/2012_Phila_PDFS/OptimizingMetastaticColorectalCancerOutcomes.pdf2012-04-04T20:05:18.000Z"c3569846ab727bf8811aab3b71d8e8b8"2118880STANDARDPLN/2012_Phila_PDFS/OptimizingMultipleMyelomaTreatment.pdf2012-04-04T20:05:38.000Z"ddab5e9aa1b6a36803da590e02caf80d"1928364STANDARDPLN/2012_Phila_PDFS/PreparingTheHealthSystemPharmacist.pdf2012-04-04T20:05:57.000Z"72ffbf07b088de05eaaceeb2eea30d84"1769911STANDARDPLN/email/2011-11-08T18:49:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/2011_reminder_images/2012-03-28T19:36:00.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/2011_reminder_images/advandx.jpg2012-03-28T19:36:09.000Z"42d5453bc1c077acf0348597c52e7e79"3851STANDARDPLN/email/2011_reminder_images/american.jpg2012-03-28T19:36:24.000Z"01c231e569b66c95e9885ab7a3e8bf19"14923STANDARDPLN/email/2011_reminder_images/bi.jpg2012-03-28T20:53:45.000Z"3ae4563be0edec667d9107ebf6393461"8274STANDARDPLN/email/2011_reminder_images/exp.jpg2012-03-28T19:36:24.000Z"02941b21cfc4191ddb3204db39ed4b62"10784STANDARDPLN/email/2011_reminder_images/forest.jpg2012-03-28T20:53:46.000Z"d63918e47aa3621ce822b05d0450f300"13096STANDARDPLN/email/2011_reminder_images/icu.jpg2012-03-28T20:55:38.000Z"f1437b9fbb4c63ae914d2aa15d3fd36c"9445STANDARDPLN/email/2011_reminder_images/janssen.jpg2012-03-28T19:36:45.000Z"698b706ae74dc32f93d74ede7fdea97a"7668STANDARDPLN/email/2011_reminder_images/medi.jpg2012-03-28T20:53:49.000Z"4f6b9bd4eb331633a91835bcc115c827"13597STANDARDPLN/email/2011_reminder_images/merck.jpg2012-03-28T19:36:30.000Z"432e252fa05c32b7da90d08d89043fce"12892STANDARDPLN/email/2011_reminder_images/novartis.jpg2012-03-28T19:36:31.000Z"7da0aa4c1405396107f7ad8085977606"18506STANDARDPLN/email/2011_reminder_images/optimer.jpg2012-03-28T20:53:50.000Z"afc08b7fba328e29f2346fc039f1ae52"5349STANDARDPLN/email/2011_reminder_images/otsuka.jpg2012-03-28T21:10:33.000Z"63111da54cc8a50e5253c37ad5751e4a"31780STANDARDPLN/email/2011_reminder_images/pfizer.jpg2012-03-28T19:36:34.000Z"2919dbac19fedfd47d8f9eff76f08c24"10381STANDARDPLN/email/2011_reminder_images/pharmedium.jpg2012-03-28T19:36:35.000Z"04de6690e0d6a978b1f875f3083be630"14872STANDARDPLN/email/2011_reminder_images/precision.jpg2012-03-28T19:36:37.000Z"38c95dfc566636698a1028671882baee"14470STANDARDPLN/email/2011_reminder_images/prostrakan.jpg2012-03-28T20:53:51.000Z"d144c0400e51a306375fef26518fb1da"15644STANDARDPLN/email/2011_reminder_images/regency.jpg2012-03-28T20:53:51.000Z"d658756f2ab9a31b6d7015c96f0c65d0"564237STANDARDPLN/email/2011_reminder_images/sagent.jpg2012-03-28T19:36:38.000Z"afc9644b7472f219be1c5e7263883f1d"16885STANDARDPLN/email/2011_reminder_images/salix_logo.jpg2012-03-28T19:36:39.000Z"6a2efb277a493b3be425cda096344230"7164STANDARDPLN/email/2011_reminder_images/sanofi.jpg2012-03-29T14:44:53.000Z"de32fcf01b66c896bd6a5f4f5ec262ee"11279STANDARDPLN/email/2011_reminder_images/seattle.jpg2012-03-28T20:57:58.000Z"4e700f90e579114cb799433ce8694ed7"12110STANDARDPLN/email/2011_reminder_images/zymo.jpg2012-03-28T19:36:39.000Z"738609e4dad53914c4f794bd8f92c37c"14326STANDARDPLN/email/2012_reminder_images/2012-03-28T20:05:23.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/CVLN newsletter Banner test.png2012-03-07T21:17:56.000Z"19d6f95b6473f7292bd710dbf3530ef3"15506STANDARDPLN/email/Eisai/2011-11-08T18:49:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/Eisai/aloxi_logo.gif2011-11-09T20:58:47.000Z"eeed423239cb365b77b5eee02f7f2d21"3774STANDARDPLN/email/Eisai/banner_arrows.gif2011-11-09T20:58:47.000Z"94f0b3f0e1ca8d07ffb673dea99ba943"3490STANDARDPLN/email/Eisai/bullet.gif2011-11-09T20:58:48.000Z"f67e5056f7f240bc4a223437ee093ec8"870STANDARDPLN/email/Eisai/eisai_logo.gif2011-11-09T20:58:48.000Z"524d35baa2eeac3481f34c8e507440ae"2402STANDARDPLN/email/Eisai/right_arrow.gif2011-11-09T20:58:48.000Z"89aa1f63b6e8fa27845230ec0c502ff5"1304STANDARDPLN/email/Eisai/swatch.gif2011-11-09T20:58:48.000Z"ce2703c3435922100c13149f5766f515"13661STANDARDPLN/email/PLN_600x100_email.jpg2011-11-09T20:58:48.000Z"dc19c0b0ea1eb9dd9e75737542060d09"76795STANDARDPLN/email/PLN_600x100_email_white.jpg2011-11-09T20:58:48.000Z"6817dd7743aa3a245a3b332a6e1f89a5"83639STANDARDPLN/email/PLN_Phila_Nov2010.html2011-11-09T20:58:49.000Z"56f5bbba4ae8e8d1c858381693b5f6ee"6205STANDARDPLN/email/PLN_Washington_Sept2010.html2011-11-09T20:58:49.000Z"8272e5fc3386711aa5d9c17575d987c7"5563STANDARDPLN/email/PLN_white_border.jpg2011-12-01T22:45:30.000Z"1d56db89268917ed2eedbadc47f4e432"17478STANDARDPLN/email/forest_enews_banner.jpg2012-03-30T17:30:26.000Z"520bc5b20d190b1a49190be1214c0abf"12382STANDARDPLN/email/hospira_enews_banner.jpg2012-03-30T17:30:27.000Z"8dda1209c82af7678936d758cda9ad75"72719STANDARDPLN/email/pln_enews/2011-11-08T18:49:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/pln_enews/hospira_leaderboard_sm.jpg2011-11-09T20:58:48.000Z"3d4682d6574cd3c0db9bb61123a72d06"29736STANDARDPLN/email/pln_enews/millennium_naccme_300x250.jpg2011-11-09T20:58:49.000Z"886568ce80bca27c866bf79002114c78"81788STANDARDPLN/email/pln_enews/naccme_sm_plnnews.gif2011-11-09T20:58:49.000Z"ad028c2fc6aca155a4d8a0e8ffd0f33a"5226STANDARDPLN/email/pln_enews/pln_header.jpg2011-11-09T20:58:49.000Z"18f47f0a5d0b1281bc08414a7eb7dd90"72687STANDARDPLN/email/pln_enews/pln_logo_plnnews.jpg2011-11-09T20:58:49.000Z"fa91746e6ccd29ba292615910d9291c1"10552STANDARDPLN/email/pln_enews/sept_2011/2011-11-08T18:49:55.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/pln_enews/sept_2011/C01_649481_728by90_v1.jpg2011-11-09T20:58:49.000Z"75615003d8f67a3ef6958f3ac86946cc"45492STANDARDPLN/email/pln_enews/sept_2011/Hospira_Med_Rectangle1.jpg2011-11-09T20:58:49.000Z"d9011520785d80f24e6ab66142d65953"34445STANDARDPLN/email/pln_logo_plnnews.jpg2011-12-01T22:45:29.000Z"fa91746e6ccd29ba292615910d9291c1"10552STANDARDPLN/email/tygacil/2011-11-08T18:49:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/tygacil/_assets/2011-11-08T18:49:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/tygacil/_assets/images/2011-11-08T18:49:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/tygacil/_assets/images/Thumbs.db2011-11-09T20:58:50.000Z"5a9e3b280f0cf678e9be5029f563333a"31744STANDARDPLN/email/tygacil/_assets/images/bottom_border.gif2011-11-09T20:58:49.000Z"dacea48da60b973bc7d097c9a5e5270d"274STANDARDPLN/email/tygacil/_assets/images/button_CABP.jpg2011-11-09T20:58:50.000Z"a8432c2b960b2f62a398027196e25126"4995STANDARDPLN/email/tygacil/_assets/images/grey1x1.jpg2011-11-09T20:58:50.000Z"d916fb738e29eced3fbd68235df2f47c"283STANDARDPLN/email/tygacil/_assets/images/greyline.jpg2011-11-09T20:58:50.000Z"56a9c01cef2c9302ab1bf60f5811157a"353STANDARDPLN/email/tygacil/_assets/images/greywhite.jpg2011-11-09T20:58:50.000Z"fc901e3bcd15ed97bcf91b4910ec9568"754STANDARDPLN/email/tygacil/_assets/images/info_CABP.jpg2011-11-09T20:58:50.000Z"af3fbb978a69b1e8841f4da0c4e5400e"10724STANDARDPLN/email/tygacil/_assets/images/news_copy.jpg2011-11-09T20:58:50.000Z"7a60f7901aace52e7110369bae04fc41"20038STANDARDPLN/email/tygacil/_assets/images/pfizer_logo.gif2011-11-09T20:58:50.000Z"50a26af95583db24d983fc00ec2d9471"1613STANDARDPLN/email/tygacil/_assets/images/product_line.jpg2011-11-09T20:58:50.000Z"e846a40f336e03f3fab6522ee02fa257"4172STANDARDPLN/email/tygacil/_assets/images/subject_line_CABP.jpg2011-11-09T20:58:50.000Z"cc5daaa1536aca1bb2f8de4a3d103616"11061STANDARDPLN/email/tygacil/_assets/images/tiger_bottom.jpg2011-11-09T20:58:51.000Z"8337bed939d5a333532bf1068f3ec6ae"8173STANDARDPLN/email/tygacil/_assets/images/tiger_top.jpg2011-11-09T20:58:51.000Z"159742dc816289a15c3acfd230ab11d1"8692STANDARDPLN/email/tygacil/_assets/img/2011-11-08T18:50:00.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/tygacil/_assets/img/Thumbs.db2011-11-09T20:58:53.000Z"e6731c89e2a0f0fd0d99fc95449ab910"196096STANDARDPLN/email/tygacil/_assets/img/Tyg_subject_line.gif2011-11-09T20:58:59.000Z"6a84ff4f139a189596f6a1857b2520df"5360STANDARDPLN/email/tygacil/_assets/img/above-learnmore.gif2011-11-09T20:58:51.000Z"1e087e0c98d228d3ebe2ef081adfb7bc"3737STANDARDPLN/email/tygacil/_assets/img/below-learnmore.gif2011-11-09T20:58:51.000Z"1e30d0492bb2802f4cf02928d50d58eb"35727STANDARDPLN/email/tygacil/_assets/img/border-bottom.gif2011-11-09T20:58:51.000Z"dacea48da60b973bc7d097c9a5e5270d"274STANDARDPLN/email/tygacil/_assets/img/border-mid-left.gif2011-11-09T20:58:51.000Z"5fefe34f045d04504db8d18eef037189"979STANDARDPLN/email/tygacil/_assets/img/border-mid-right.gif2011-11-09T20:58:51.000Z"23e7e2aab6467f28b37b80447c41e2a0"1050STANDARDPLN/email/tygacil/_assets/img/border-top-left.gif2011-11-09T20:58:51.000Z"e386ac786613b5a7e9efc339791e08aa"111STANDARDPLN/email/tygacil/_assets/img/border-top-right.gif2011-11-09T20:58:51.000Z"107cb117b6d1bf1aa7a46abc247aae00"111STANDARDPLN/email/tygacil/_assets/img/border-top.gif2011-11-09T20:58:52.000Z"67606701a53581860f47803be22f9b7c"152STANDARDPLN/email/tygacil/_assets/img/bottom_border.gif2011-11-09T20:58:52.000Z"dacea48da60b973bc7d097c9a5e5270d"274STANDARDPLN/email/tygacil/_assets/img/doctornet_add.gif2011-11-09T20:58:52.000Z"9b37a6e02756be59fa4e5421a53a249e"2017STANDARDPLN/email/tygacil/_assets/img/double-top-divider.gif2011-11-09T20:58:52.000Z"bfc149e609bb12891a5f3687a984da5c"335STANDARDPLN/email/tygacil/_assets/img/learn-more.gif2011-11-09T20:58:52.000Z"348df794e7fe6cdcd325298c6e9f52c2"4192STANDARDPLN/email/tygacil/_assets/img/pfizer_logo.gif2011-11-09T20:58:52.000Z"50a26af95583db24d983fc00ec2d9471"1613STANDARDPLN/email/tygacil/_assets/img/product-line.gif2011-11-09T20:58:52.000Z"632f679f4f526e6edfc475435a39ebc6"2940STANDARDPLN/email/tygacil/_assets/img/purple_bullet.gif2011-11-09T20:58:52.000Z"4c15aeecff3446d07780caeb2a71b16c"68STANDARDPLN/email/tygacil/_assets/img/single-top-divider.gif2011-11-09T20:58:52.000Z"e39b75182b62e0615d8c10a635027dfe"209STANDARDPLN/email/tygacil/_assets/img/subject-line.gif2011-11-09T20:58:53.000Z"610d3f073c6531dd5bbf7ccfe2f6d7b8"1463STANDARDPLN/email/tygacil/_assets/img/tiger-back-new.gif2011-11-09T20:58:58.000Z"17d1a3d10dc450e356688335601ab92a"29026STANDARDPLN/email/tygacil/_assets/img/tiger-back.gif2011-11-09T20:58:58.000Z"e324b83bc1a41b08c698738129b2c139"18779STANDARDPLN/email/tygacil/_assets/img/tiger/2011-11-08T18:50:05.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/email/tygacil/_assets/img/tiger/Thumbs.db2011-11-09T20:58:53.000Z"b5c2e9bf6f1be6a76e78148aa73027ee"128512STANDARDPLN/email/tygacil/_assets/img/tiger/below-learnmore.gif2011-11-09T20:58:53.000Z"1e30d0492bb2802f4cf02928d50d58eb"35727STANDARDPLN/email/tygacil/_assets/img/tiger/tiger-back-new.gif2011-11-09T20:58:54.000Z"17d1a3d10dc450e356688335601ab92a"29026STANDARDPLN/email/tygacil/_assets/img/tiger/tygacil_email_siteUpdates_6_REFERENCE.psd2011-11-09T20:58:54.000Z"b9b5156c326f31a702ce7886e7876e00-3"12674976STANDARDPLN/email/tygacil/_assets/img/tygacil-com.gif2011-11-09T20:58:58.000Z"6d430c5a9ac7f2f8e2a700a151c8fe13"658STANDARDPLN/index.php2011-11-09T20:58:59.000Z"40f86e5cdc0f93d23332ab98114477c5"409STANDARDPLN/pdfs/2011-11-08T18:50:08.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/pdfs/AcuteCoronarySyndromes_5-11.pdf2011-11-09T20:58:59.000Z"44e2897593afeae0dd3a2d981e9db0c1"3227187STANDARDPLN/pdfs/CKD-InducedAnemia_5-11.pdf2011-11-09T20:59:01.000Z"c2c573aff9685ce32c0ff6c02ac14507"892813STANDARDPLN/pdfs/Depression_5-11.pdf2011-11-09T20:59:01.000Z"e0d6dbdbe6d396c9bcb34998c663bb3d"349766STANDARDPLN/pdfs/Diabetes_5-11.pdf2011-11-09T20:59:02.000Z"9a26cb186854aabb4bb879f9614bd40d"897613STANDARDPLN/pdfs/Hemostasis_5-11.pdf2011-11-09T20:59:02.000Z"6840c712417dd434c472d9a5577a981c"1387461STANDARDPLN/pdfs/HotTopics_5-11.pdf2011-11-09T20:59:03.000Z"ed24f019f9ac2a1e1a9ed41085cdf36d"810441STANDARDPLN/pdfs/Hyponatremia_5-11.pdf2011-11-09T20:59:04.000Z"703b187b99e50894a647763127328ecb"1986913STANDARDPLN/pdfs/InfectionControl_5-11.pdf2011-11-09T20:59:05.000Z"dce78b934dd16280d8dc388cda2b0822"1111357STANDARDPLN/pdfs/MedicationErrorsREMS_5-11.pdf2011-11-09T20:59:05.000Z"087e4a81c6294d1fa3f251cb9fd7ebd2"2204709STANDARDPLN/pdfs/MetastaticMelanoma_5-11.pdf2011-11-09T20:59:07.000Z"a625b534b61056b54bad80250f3106b4"755603STANDARDPLN/pdfs/Ophthalmology_5-11.pdf2011-11-09T20:59:07.000Z"07a7a09d5db3f019c2edc9ee49cdfd32"2018693STANDARDPLN/pdfs/PLN_Winter2011_eNews_1.pdf2011-11-30T18:29:34.000Z"2f5cd9a54d9770c51bcc73e8117f8d98"18100STANDARDPLN/pdfs/PharmacyLaw_5-11.pdf2011-11-09T20:59:08.000Z"df9313dba771a16a0f6c62034aba39d4"277951STANDARDPLN/pdfs/VenousThromboembolism_5-11.pdf2011-11-09T20:59:08.000Z"e11cd82153d2bb30b85b5212b95cb6a8"1035278STANDARDPLN/press_release_october2010.pdf2011-11-09T20:59:09.000Z"3aa8b33079b901d31450faf086628e9f"54936STANDARDPLN/webcasts/2011-11-08T18:50:14.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-18_Hyponatremia/2011-11-08T18:50:14.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1.html2011-11-09T20:59:09.000Z"8934d50fcbd275b6fd2bfab3c8945678"3731STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1.js2011-11-09T20:59:09.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1.mp42011-11-09T20:52:47.000Z"7d6e51db4d9a7ba5831007f5bf1114c1-10"48322849STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1_config.xml2011-11-09T20:59:14.000Z"18f7d2a2eeeeb84a8521b85cf33fe7e6"8122STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1_controller.swf2011-11-09T20:59:15.000Z"695334aacb48f944f9d3adacc3c397ab"190207STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1_nofp_bg.gif2011-11-09T20:59:16.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-18_Hyponatremia/Hyponatremia_V1_preload.swf2011-11-09T20:59:16.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-18_Hyponatremia/ProductionInfo.xml2011-11-09T20:59:16.000Z"8616933dc2249337fec3bba59016b4a1"14521STANDARDPLN/webcasts/366-18_Hyponatremia/hyponatremia_screen.jpg2011-11-09T20:59:09.000Z"54f45c689bca51245884ccbac65c9575"58209STANDARDPLN/webcasts/366-18_Hyponatremia/swfobject.js2011-11-09T20:59:16.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/366-37_ACS/2011-11-08T18:50:18.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-37_ACS/ACS_V1.html2011-11-09T20:59:17.000Z"4b4cd113d7f64d35d5a0d7cd99e6897a"3641STANDARDPLN/webcasts/366-37_ACS/ACS_V1.js2011-11-09T20:59:17.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-37_ACS/ACS_V1.mp42011-11-09T20:59:17.000Z"e3a995e56b8d032d415631ebefa197b7-14"69808592STANDARDPLN/webcasts/366-37_ACS/ACS_V1_config.xml2011-11-09T20:59:37.000Z"cd5f07c99e3c622717a5ecc06ece8ed2"16284STANDARDPLN/webcasts/366-37_ACS/ACS_V1_controller.swf2011-11-09T20:59:37.000Z"4806932d5177a15d70089e5824a51059"190199STANDARDPLN/webcasts/366-37_ACS/ACS_V1_nofp_bg.gif2011-11-09T20:59:38.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-37_ACS/ACS_V1_preload.swf2011-11-09T20:59:38.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-37_ACS/ACS_screen.jpg2011-11-09T20:59:17.000Z"6618adc88ed9e564f8427ee7fec08797"102460STANDARDPLN/webcasts/366-37_ACS/ProductionInfo.xml2011-11-09T20:59:38.000Z"f61f6fa6d1f9fd49edcb5c92ca2c85fe"24734STANDARDPLN/webcasts/366-37_ACS/swfobject.js2011-11-09T20:59:38.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/366-5_Hemostasis/2011-11-08T18:50:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2.html2011-11-09T20:59:38.000Z"fe83f0ae516fa61fe05529fbad8f7b4a"3749STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2.js2011-11-09T20:59:38.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2.mp42011-11-09T20:59:38.000Z"cf7c4c507834b579cc74d4583ef49c8e-20"102814973STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2_config.xml2011-11-09T21:00:08.000Z"fa4b44819523c82798b48c2a7a977c39"23961STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2_controller.swf2011-11-09T21:00:08.000Z"80d76ec0503dbdede1aeed4c450c43e5"189048STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2_nofp_bg.gif2011-11-09T21:00:09.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_V2_preload.swf2011-11-09T21:00:09.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-5_Hemostasis/Hemostasis_screen.jpg2011-11-09T20:59:38.000Z"3a02995825c7c8058798d94b87b89ed7"66702STANDARDPLN/webcasts/366-5_Hemostasis/ProductionInfo.xml2011-11-09T21:00:09.000Z"a477cc6321bebc1ea8465dce0cc9088f"34432STANDARDPLN/webcasts/366-5_Hemostasis/swfobject.js2011-11-09T21:00:09.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/366-7_MedErrors/2011-11-08T18:50:37.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-7_MedErrors/ISMP_logo.png2011-11-09T21:00:09.000Z"79a6cea204830b5d06aa1adaa7b284e0"8811STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2.html2011-11-09T21:00:09.000Z"fea38ba70c568304a8a5e12cad8ebb4e"3686STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2.js2011-11-09T21:00:09.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2.mp42011-11-09T21:00:10.000Z"64a5c9c3fcfe7b4f75977012560d665c-24"124690758STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2_config.xml2011-11-09T21:00:46.000Z"192c4a6e6db5d74b4f685136173fd856"19159STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2_controller.swf2011-11-09T21:00:46.000Z"32513883a4b6ac3eb7a976c392bc17d8"189048STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2_nofp_bg.gif2011-11-09T21:00:47.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-7_MedErrors/MedErrors_V2_preload.swf2011-11-09T21:00:47.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-7_MedErrors/PLN_logo_sm.gif2011-11-09T21:00:47.000Z"d5ba57933b6797accf18a78d94975313"2800STANDARDPLN/webcasts/366-7_MedErrors/ProductionInfo.xml2011-11-09T21:00:47.000Z"8bff377cf51517433fcdd41b5881cc80"28408STANDARDPLN/webcasts/366-7_MedErrors/mederrors_screen.jpg2011-11-09T21:00:09.000Z"26a73d15ba9d03997e619adb7613da9b"72919STANDARDPLN/webcasts/366-7_MedErrors/swfobject.js2011-11-09T21:00:47.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/366-7_MedErrors/uk_logo_new.jpg2011-11-09T21:00:47.000Z"a08a3c36abe45488c0f6ab2edbb550f2"10594STANDARDPLN/webcasts/366-8_Myeloma/2011-11-08T18:50:48.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10.html2011-11-09T21:00:47.000Z"f02ba5b58afc5a8ef670e4ec06ab4547"3809STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10.js2011-11-09T21:00:47.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10.mp42011-11-09T21:00:48.000Z"52fa5b96ecda009ce1fc69965226cccc-17"87833801STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10_config.xml2011-11-09T21:01:13.000Z"4432051732192482a023b21b68253dfb"16227STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10_controller.swf2011-11-09T21:01:13.000Z"4b96e776edc9b94d634a5423b2520030"189053STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10_nofp_bg.gif2011-11-09T21:01:13.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-8_Myeloma/Myeloma_v2_12.21.10_preload.swf2011-11-09T21:01:13.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-8_Myeloma/ProductionInfo.xml2011-11-09T21:01:13.000Z"8718c05d99d54e1c79de59c2b9a7ed06"60042STANDARDPLN/webcasts/366-8_Myeloma/myeloma_screen.jpg2011-11-09T21:00:47.000Z"30101ca2df6e1a6474c107a3e58f2269"64161STANDARDPLN/webcasts/366-8_Myeloma/swfobject.js2011-11-09T21:01:13.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/366-9_RSV/2011-11-08T18:50:57.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/366-9_RSV/ProductionInfo.xml2011-11-09T21:01:13.000Z"40f35aeae42a30ee5f0a5401d0bab914"31921STANDARDPLN/webcasts/366-9_RSV/RSV_V2.html2011-11-09T21:01:14.000Z"e45e7276f3ec7372da290e5805018cb3"3679STANDARDPLN/webcasts/366-9_RSV/RSV_V2.js2011-11-09T21:01:14.000Z"4bf5e48753dd5fadb381bfe1005967de"541STANDARDPLN/webcasts/366-9_RSV/RSV_V2.mp42011-11-09T21:01:14.000Z"6ea5b293baa2df322092c2ec23477039-16"80484092STANDARDPLN/webcasts/366-9_RSV/RSV_V2_config.xml2011-11-09T21:01:37.000Z"0c37b4658d082aa9a35dcf7af9aa23d3"22177STANDARDPLN/webcasts/366-9_RSV/RSV_V2_controller.swf2011-11-09T21:01:38.000Z"049756ae79f6147c289c9750cffbeab8"189044STANDARDPLN/webcasts/366-9_RSV/RSV_V2_nofp_bg.gif2011-11-09T21:01:38.000Z"445b3fe2a177034855b9702da1fad0a2"13002STANDARDPLN/webcasts/366-9_RSV/RSV_V2_preload.swf2011-11-09T21:01:38.000Z"b852fff6519b01e950ad519f4d9400df"13905STANDARDPLN/webcasts/366-9_RSV/RSV_screen.jpg2011-11-09T21:01:14.000Z"b82d00877ea0a1ce39b6189e64b94def"77522STANDARDPLN/webcasts/366-9_RSV/swfobject.js2011-11-09T21:01:38.000Z"d0a40017983ecafa80fb0e2e92d5f692"9763STANDARDPLN/webcasts/MedErrors/2011-11-08T18:51:06.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDPLN/webcasts/MedErrors/ISMP_logo.png2011-11-09T21:01:38.000Z"79a6cea204830b5d06aa1adaa7b284e0"8811STANDARDPLN/webcasts/MedErrors/PLN_logo_sm.gif2011-11-09T21:01:38.000Z"d5ba57933b6797accf18a78d94975313"2800STANDARDPLN/webcasts/MedErrors/mederrors_screen.jpg2011-11-09T21:01:38.000Z"26a73d15ba9d03997e619adb7613da9b"72919STANDARDPLN/webcasts/MedErrors/uk_logo_new.jpg2011-11-09T21:01:38.000Z"a08a3c36abe45488c0f6ab2edbb550f2"10594STANDARDTWP-12-902bostonheader387x150.jpeg2012-05-15T21:16:01.000Z"218b2a22f2a5fa30800e20ec9097b05d"62770STANDARDUSPCemailheader.jpg2012-05-03T20:21:45.000Z"e0d8e881f6c7ac13c935d921c2a0ac41"61679STANDARDUnknown-1.jpeg2012-05-10T13:22:36.000Z"d94c70b8f76b39618af9c7506f4f8fb7"111832STANDARDbackups/2012-05-11T16:00:07.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDbackups/database/2012-05-11T16:01:14.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDbackups/database/NACCME-2012-05-11--14-23-36.mysql.gz2012-05-11T18:24:10.000Z"323411e90e33753aa073356453167beb"15773586STANDARDbackups/database/NACCME-2012-05-11--14-23-36.mysql.gz.info2012-05-11T18:24:10.000Z"b920d3125c2c30de902e4937639d913e"326STANDARDbackups/database/NACCME-2012-05-12--14-09-53.mysql.gz2012-05-12T18:10:28.000Z"4d029351119d416082d6dd1fe2ee225f"15784550STANDARDbackups/database/NACCME-2012-05-12--14-09-53.mysql.gz.info2012-05-12T18:10:27.000Z"e70167e46733d2563f07c1694df3b311"326STANDARDbackups/database/NACCME-2012-05-13--13-55-44.mysql.gz2012-05-13T17:56:18.000Z"5f715349ec801198539144e2dc566890"15795517STANDARDbackups/database/NACCME-2012-05-13--13-55-44.mysql.gz.info2012-05-13T17:56:18.000Z"c98409220072940fd14ed7326c2fc0c2"326STANDARDbackups/database/NACCME-2012-05-14--13-41-27.mysql.gz2012-05-14T17:42:02.000Z"49ad7e2073b5111db9c027871399fd8f"15827434STANDARDbackups/database/NACCME-2012-05-14--13-41-27.mysql.gz.info2012-05-14T17:42:02.000Z"133ffd297c9469bbccfdadb72eee4fd1"330STANDARDbackups/database/NACCME-2012-05-15--13-27-13.mysql.gz2012-05-15T17:27:49.000Z"2232c8a3ab4a59c6185c73eab578c9e4"15910628STANDARDbackups/database/NACCME-2012-05-15--13-27-13.mysql.gz.info2012-05-15T17:27:49.000Z"657520b320a43f158cefe57796de1757"330STANDARDbackups/database/NACCME-2012-05-16--13-12-50.mysql.gz2012-05-16T17:13:26.000Z"3effe821ad0dc4a3a82e002ab40b2ef6"15978482STANDARDbackups/database/NACCME-2012-05-16--13-12-50.mysql.gz.info2012-05-16T17:13:26.000Z"caebdc858c10e843a6b86e3fc0166c17"326STANDARDbackups/database/NorthAmericanCenterforContinuingMedicalEducation-2012-05-11T12-53-45.mysql.gz2012-05-11T16:54:19.000Z"2ba71ef4bc00cf237b7bd9befed91a28"15767560STANDARDbackups/database/NorthAmericanCenterforContinuingMedicalEducation-2012-05-11T12-53-45.mysql.gz.info2012-05-11T16:54:19.000Z"24553da4aff45a17a5bd3693b0f9feb0"367STANDARDbackups/files/2012-05-11T19:43:06.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDbackups/files/NACCME-2012-05-11--15-42-47.tar.gz2012-05-11T19:42:58.000Z"0328599679d63d435b021dfb7fa28d9c"32287822STANDARDbackups/files/NACCME-2012-05-11--15-42-47.tar.gz.info2012-05-11T19:42:58.000Z"ac476f8f33ed74474806825fd53aea2e"41STANDARDbackups/files/NACCME-2012-05-12--15-28-50.tar.gz2012-05-12T19:29:01.000Z"70bf4f4a3c54ad7a5e31e09260577d74"32287256STANDARDbackups/files/NACCME-2012-05-12--15-28-50.tar.gz.info2012-05-12T19:29:00.000Z"c00db1e76af40256c8eca4907c759b3b"41STANDARDbackups/files/NACCME-2012-05-13--15-14-50.tar.gz2012-05-13T19:15:00.000Z"855167e6786b2fba9a61f1e3de61a5ad"32287274STANDARDbackups/files/NACCME-2012-05-13--15-14-50.tar.gz.info2012-05-13T19:15:00.000Z"ff9bf733d4c1e91f55642202d75d5dde"41STANDARDbackups/files/NACCME-2012-05-14--15-00-35.tar.gz2012-05-14T19:00:46.000Z"4daceba5b655a0fb1957d564db97aa26"32370869STANDARDbackups/files/NACCME-2012-05-14--15-00-35.tar.gz.info2012-05-14T19:00:46.000Z"cd5079d029b0ec407f4471e8150d99e3"41STANDARDbackups/files/NACCME-2012-05-15--14-46-12.tar.gz2012-05-15T18:46:23.000Z"67160c7aa9159083a7dea37099322b0b"32530879STANDARDbackups/files/NACCME-2012-05-15--14-46-12.tar.gz.info2012-05-15T18:46:23.000Z"659860185fc01ce9fe44a8b8fc5a23d1"41STANDARDbackups/files/NACCME-2012-05-16--14-31-50.tar.gz2012-05-16T18:32:01.000Z"a5102af85b7528deeda0f1775c819e9d"32531078STANDARDbackups/files/NACCME-2012-05-16--14-31-50.tar.gz.info2012-05-16T18:32:00.000Z"7867e75d9930b6b3c228baa326f044e6"41STANDARDbanners/2011-11-28T21:21:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDbanners/2012-455-12_Banner_Ad.jpg2012-05-15T21:05:37.000Z"d3a9d242b9f06dea6ed5b8d083e2752e"49759STANDARDbanners/CF-12-250x300.jpg2012-03-02T21:38:17.000Z"25e7ad8ecc2f5821e1cedf6e7983d5a4"86089STANDARDbanners/PLN_banner_dec_13_250-250.jpg2011-12-12T14:42:01.000Z"1b011614e9fb44429710e9eb28a2542d"86284STANDARDbanners/SAWC_Healthpoint_12-455-5_250x300b.jpg2012-03-23T20:54:15.000Z"dec682daf9d043cf26e35c7af847a3da"48398STANDARDbanners/Sagent_Gemcitabine_WebBanner_b03.gif2011-12-01T19:36:45.000Z"5efd155208d56c0c0c92c24ba25d76c9"62056STANDARDbanners/janssen_banner_dec2011.jpg2011-12-01T19:32:20.000Z"5b4eddccfdc1ce51a7d3ccc9eca04c10"45241STANDARDbanners/odyssey_banner3.jpg2011-11-28T21:22:13.000Z"3d7906de3299b5d838d5d38db5e3019e"108748STANDARDbanners/pln_2012_dates.jpg2012-02-08T18:13:30.000Z"12d3c77b06e1dbd5d239f17c78fdd838"107496STANDARDbanners/pln_2012_dates_2.jpg2012-02-10T20:39:52.000Z"61750344936379b60b3e25b2646c0a19"108113STANDARDbanners/pln_2012_dates_3.jpg2012-02-28T17:30:26.000Z"bb7063963cb8c0be004cec2c06cca257"107623STANDARDimages/2011-11-10T16:06:58.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/buttons/2012-04-19T14:35:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/buttons/access_simulcast_btn.jpg2012-04-19T14:43:59.000Z"0a8109ed9c35e37a5e28478cbab10af4"5049STANDARDimages/certs/2011-11-16T00:47:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/certs/ACPE.gif2012-02-09T15:15:21.000Z"94adfd2775ba48ea5f4718c70854dd3b"425STANDARDimages/certs/dietitian_logo.jpg2011-12-09T21:12:01.000Z"dee91d0a4c0a2b10636f818953930030"5700STANDARDimages/certs/john_kues_sig.jpg2012-04-27T15:42:35.000Z"145b0d2b455de89f2c9dd257b6beb3b9"3608STANDARDimages/certs/js_sig.gif2011-11-16T00:51:53.000Z"3db3ca68b9b7a04e418d981b48e55b6e"2002STANDARDimages/certs/naccme_med.jpg2011-11-16T00:51:53.000Z"408664b56431d9b177fa7eaf81b3ecb5"10763STANDARDimages/email/2011-11-16T19:28:31.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/2012_templates/2012-05-14T15:40:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/2012_templates/cflc_embanner_2012.jpg2012-05-14T15:53:33.000Z"af9251f6d103a25f18fd13aab4d7b446"74249STANDARDimages/email/2012_templates/core_embanner_2012.jpg2012-05-14T15:53:34.000Z"8f53cd73df8eed7fa05ef48f0884f48d"80395STANDARDimages/email/2012_templates/cvln_embanner_2012.jpg2012-05-14T15:53:35.000Z"5306bcc1f8555e7f81f8b401bb4d99fe"81975STANDARDimages/email/2012_templates/mcln_embanner_2012.jpg2012-05-14T15:53:35.000Z"c6278f4d7d731b75bc82aaf7577aeb37"60554STANDARDimages/email/2012_templates/naccme2_embanner_2012.jpg2012-05-14T15:53:39.000Z"cdd1dfd0d8fafee50da7fa077b8f8b5e"67066STANDARDimages/email/2012_templates/naccme_embanner_2012.jpg2012-05-14T15:53:38.000Z"0949d1d1e18a213f1390f20d089dd9d9"73172STANDARDimages/email/2012_templates/oln_embanner_2012.jpg2012-05-14T15:53:41.000Z"e28df31e5c80d04c1bbd40ca83ef6550"60436STANDARDimages/email/2012_templates/pln_embanner_2012.jpg2012-05-14T15:53:43.000Z"3b1c9ebc59324dbf8ef3ac3b52333f32"82458STANDARDimages/email/2012_templates/sawc_embanner_2012.jpg2012-05-14T15:53:43.000Z"3280ae1a1f4c01021c399860322d3a23"90107STANDARDimages/email/2012_templates/social_facebook.gif2012-05-15T14:18:45.000Z"2c825905582d5bd6065088f45a0956df"1348STANDARDimages/email/2012_templates/social_twitter.gif2012-05-14T19:02:35.000Z"177f1e0f710f55518518bf31a0675bca"788STANDARDimages/email/CME_LLC/2012-05-02T15:00:19.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/CME_LLC/conference_5_2_12/2012-05-02T15:10:24.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/CME_LLC/conference_5_2_12/CME_LLC_logo.jpg2012-05-02T15:10:37.000Z"f6b614b8ea833024df08b2e5cfb983a6"5894STANDARDimages/email/CME_LLC/conference_5_2_12/Exhibitor_Header.jpg2012-05-02T16:42:34.000Z"e9f4ac2fa5b9d68cdfd13884f2f13043"67171STANDARDimages/email/CME_LLC/conference_5_2_12/linkedin_icon.jpg2012-05-02T15:10:37.000Z"796a36d9323722da9b8a5f3dd8c11bc5"2710STANDARDimages/email/CME_LLC/conference_5_2_12/tables.jpg2012-05-02T15:25:33.000Z"9c0a8fbb58127d83bddffb4af371d4d6"29833STANDARDimages/email/CME_LLC/conference_5_2_12/twitter-icon.jpg2012-05-02T15:10:37.000Z"39e59d82189c4061bdbf4de677ef5458"2792STANDARDimages/email/CRS header.jpg2012-02-28T20:12:50.000Z"80215967bdea8aec586415b735f01b1c"89089STANDARDimages/email/CVLN lead picture.png2012-02-07T18:59:39.000Z"b548a5ee58c17e7859df1fb824b5c97b"162065STANDARDimages/email/FINAL_CVLN_Odyssey_LiveBroadcast.html2012-03-05T20:59:51.000Z"b588ba80205f7e46c06f5faf00809894"7273STANDARDimages/email/Optimize postcard.png2012-03-07T17:49:06.000Z"10ed75e513cac8d6e3fd800ff734538d"283826STANDARDimages/email/cvln_texas_live/2012-02-21T16:28:28.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/cvln_texas_live/burkhardt.jpg2012-02-21T16:51:37.000Z"6c549b7d013c1b188bb116681380aa61"4407STANDARDimages/email/cvln_texas_live/horton.jpg2012-02-21T16:51:38.000Z"7798aef5c03209fda4642847212f70ad"4202STANDARDimages/email/cvln_texas_live/texas_logo.jpg2012-02-21T22:43:58.000Z"bf0e3aa017f4c108f369703379f7ce74"16376STANDARDimages/email/facebook_logo_box.jpg2012-02-16T21:31:17.000Z"c3a1d4dd0dbff059af8982672e680460"5536STANDARDimages/email/facebook_logo_trans.gif2012-02-16T21:34:22.000Z"d759239eaf3460975965b47f39e0bfd6"2554STANDARDimages/email/facebook_square.gif2012-02-16T22:02:55.000Z"78353a8ccd84eae43406a7e12c1716fb"2300STANDARDimages/email/naccme_facebook.jpg2012-02-01T18:51:06.000Z"d9fa7b08ba9b8df203518e0adc11ebc3"6446STANDARDimages/email/naccme_twitter.jpg2012-02-01T18:55:24.000Z"884c337e0dd3761b0760e775197be6a5"4650STANDARDimages/email/odyssey_feb_2012/2012-02-24T16:03:29.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/odyssey_feb_2012/eplive_blue.jpg2012-02-24T20:18:34.000Z"31f1f43e36184ab8b8bd174ed122dfdb"20849STANDARDimages/email/odyssey_feb_2012/eplive_logo.jpg2012-02-24T16:03:52.000Z"e337416e6338a626bb6096393adbe0c7"15422STANDARDimages/email/odyssey_jan_2012/2012-01-04T20:48:51.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/odyssey_jan_2012/hospitals.jpg2012-01-04T20:49:13.000Z"4c56754d39108b1ab8c9b2a48f90d1d1"47163STANDARDimages/email/odyssey_jan_2012/logos.jpg2012-01-04T20:49:14.000Z"970f86b06d9dc7057f96cb021944e6c5"35321STANDARDimages/email/odyssey_jan_2012/naccme.jpg2012-01-04T20:49:15.000Z"73b06f0c2fb9ebb37e83e4311221fd75"29958STANDARDimages/email/odyssey_jan_2012/register_now.jpg2012-01-04T21:37:01.000Z"302907c110f9042d2d885f202fd60266"2096STANDARDimages/email/pln_enews/2011-11-30T17:41:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_enews/dec_2011/2011-11-30T18:17:02.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_enews/dec_2011/dec11_feature_img.jpg2011-11-30T20:45:59.000Z"1a9e50174b97c021fc8f5cb72c22bc0a"33629STANDARDimages/email/pln_enews/dec_2011/dec11_feature_img2.jpg2011-11-30T21:07:25.000Z"43569a31791da6f6827742eb4cb6356d"34118STANDARDimages/email/pln_enews/facebook.jpg2011-11-30T19:30:10.000Z"adab8a830453f8650c065d0561e4cf28"1956STANDARDimages/email/pln_enews/hospira_leaderboard_sm.jpg2011-11-30T17:44:26.000Z"3d4682d6574cd3c0db9bb61123a72d06"29736STANDARDimages/email/pln_enews/millennium_naccme_300x250.jpg2011-11-30T17:44:27.000Z"886568ce80bca27c866bf79002114c78"81788STANDARDimages/email/pln_enews/naccme_sm_plnnews.gif2011-11-30T17:44:28.000Z"ad028c2fc6aca155a4d8a0e8ffd0f33a"5226STANDARDimages/email/pln_enews/pln_header.jpg2011-11-30T17:44:28.000Z"18f47f0a5d0b1281bc08414a7eb7dd90"72687STANDARDimages/email/pln_enews/pln_logo_plnnews.jpg2011-11-30T17:44:30.000Z"fa91746e6ccd29ba292615910d9291c1"10552STANDARDimages/email/pln_enews/sept_2011/2011-11-30T17:45:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_enews/sept_2011/C01_649481_728by90_v1.jpg2011-11-30T17:45:45.000Z"75615003d8f67a3ef6958f3ac86946cc"45492STANDARDimages/email/pln_enews/sept_2011/Hospira_Med_Rectangle1.jpg2011-11-30T17:45:45.000Z"d9011520785d80f24e6ab66142d65953"34445STANDARDimages/email/pln_enews/twitter.jpg2011-11-30T19:30:10.000Z"cfaf68053becac51d32303c480256324"1606STANDARDimages/email/pln_evolution_pr_jan2012/2012-01-24T20:28:56.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_evolution_pr_jan2012/PLN_pr_evolution.jpg2012-01-24T21:58:27.000Z"7260c70c9c410b7159698341dc774428"65938STANDARDimages/email/pln_oncology_pr_jan2012/2012-01-11T19:33:13.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_oncology_pr_jan2012/PLN_PR_OncologyHeader.jpg2012-01-11T19:33:46.000Z"a7a10b99f99fd88355f16f2facbcc6b8"64528STANDARDimages/email/pln_postcard_feb2012/2012-02-16T19:43:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/pln_postcard_feb2012/PLN_Oncology_600.jpg2012-02-16T20:16:38.000Z"71cb8e673b07ab779059fa0e2fa6d1af"244196STANDARDimages/email/pln_postcard_feb2012/PLN_Oncology_600_2.jpg2012-02-17T16:05:30.000Z"d624702b5770668bd43b75b6e5713a2f"248122STANDARDimages/email/pln_postcard_feb2012/pln_onc_botfader.jpg2012-02-16T20:28:16.000Z"3b5857436208ad6d4e407c9b9b244625"2090STANDARDimages/email/twitter_square.gif2012-02-16T22:12:21.000Z"efcedd50af0e7b20f3d8d144bd8254bf"2359STANDARDimages/email/vha_side.jpg2011-11-16T19:28:48.000Z"4a67e23152e4ff933ff552ab20fcf156"1842STANDARDimages/email/vha_title.jpg2011-11-21T20:57:10.000Z"0c91dd085100dd7e9a1502ce0d1e5805"11066STANDARDimages/email/vha_top.jpg2011-11-16T19:28:48.000Z"6fe204f769ebf1891cfbedd288fbf83f"5715STANDARDimages/email/xarelto_dec_2011/2011-12-01T15:30:36.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/email/xarelto_dec_2011/Xarelto_02x11137.htm2011-12-01T16:19:01.000Z"0bc9bac592b67ac6951a660c0e75de5b"46297STANDARDimages/email/xarelto_dec_2011/bullet-sub.gif2011-12-01T15:35:48.000Z"0bfb5d31f5066e1d70c3c34966d55a6d"186STANDARDimages/email/xarelto_dec_2011/bullet.gif2011-12-01T15:35:48.000Z"fd14a3da2fb4b30d6cdbf0a878341799"127STANDARDimages/email/xarelto_dec_2011/footer.jpg2011-12-01T15:35:49.000Z"7c556daebdcde51a16cf257c7e1afff9"13850STANDARDimages/email/xarelto_dec_2011/graytable_line.gif2011-12-01T15:35:49.000Z"0634a61d41ca875d3c761d85e74bd1f8"43STANDARDimages/email/xarelto_dec_2011/header.gif2011-12-01T15:35:49.000Z"4ac4a222de82fcec5a1fb159539e45a9"66927STANDARDimages/email/xarelto_dec_2011/janssen-logo.gif2011-12-01T15:35:51.000Z"577d931e0db0f7108b452872c6c7b5b5"3058STANDARDimages/email/xarelto_dec_2011/trans.gif2011-12-01T15:35:51.000Z"ad480fd0732d0f6f1a8b06359e3a42bb"43STANDARDimages/logos/2011-11-10T16:07:05.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/logos/489 slide cover.png2012-03-08T20:11:50.000Z"ad30714ba24bf0852f370ae84315dd4b"20520STANDARDimages/logos/AF Ablation--Postcard.png2012-02-27T19:42:04.000Z"411e53c84a905d135a1cce2c5a322c05"107923STANDARDimages/logos/All_pharmacists_12_15_11.csv2012-03-09T22:42:23.000Z"0ae7249ea27bbf01112ca45afbbff7a0"5204322STANDARDimages/logos/Becton Dickinson Logo.jpg2012-05-09T12:47:41.000Z"f1746972b3acb1ee34efb445a2929163"38246STANDARDimages/logos/CF learning Center logo banner copy.gif2012-03-13T18:47:06.000Z"149cb4f0eb8dbdb13568ecd436010a91"15762STANDARDimages/logos/CIN postcard img.png2012-03-06T14:25:11.000Z"8f53ba3d952c12f5d4ccf7206cc33e38"850304STANDARDimages/logos/CORE logo sized.jpg2012-02-03T15:09:43.000Z"b3c13d9e177d3df0ac3f43ff82ccf8e5"42934STANDARDimages/logos/CVLN E-Newsletter banner v1.png2012-03-08T20:01:15.000Z"efb9ecc5b42db0b083c71c73642e8a88"61421STANDARDimages/logos/CVLN blast logo sized.jpg2012-02-03T16:34:52.000Z"b26763a5d9a811a2218bb2371fbe9424"34952STANDARDimages/logos/CVLN logo Sized.jpg2012-02-03T14:59:55.000Z"30af88b1bb575289cb20fa9a35451e4a"39365STANDARDimages/logos/Cadence Logo.JPG2012-05-09T12:47:42.000Z"246fe06ee9fd25bc1e073149ada81215"15884STANDARDimages/logos/Celgene Logo.JPG2012-05-09T13:51:16.000Z"fdce858e4c8beadb780b1cad87c2092c"92720STANDARDimages/logos/Consultant banner.png2012-04-03T18:53:24.000Z"e7807ff2995dc9bc786b3eaa820218f2"190303STANDARDimages/logos/Facebook and twitter buttons.png2012-02-01T15:59:09.000Z"2a92620f3962a67f4f7931da9b9debe4"13091STANDARDimages/logos/Facebook+and+twitter+buttons alpha.png2012-02-29T15:20:36.000Z"63afefe582ec58d4e95313e29abe823a"17214STANDARDimages/logos/MCLN balance card.png2012-03-08T18:14:36.000Z"6c5426d3c4b1d365832d81ac1b808589"139831STANDARDimages/logos/MCLN banner R[1].jpg2012-02-06T14:39:37.000Z"1445cbd7ed145780d01cba7a56a401c6"102988STANDARDimages/logos/MCLN boxed ® Sized.jpg2012-02-03T14:27:18.000Z"d7ecd16d262d2c57cadadd09789cf892"19049STANDARDimages/logos/MCLN with text TM Sized.jpg2012-02-03T15:54:37.000Z"945d490ed2502a7408af776865497667"47617STANDARDimages/logos/MCLN_boxed_®_Sized_alpha.jpg2012-03-08T20:19:50.000Z"fb6a0e5a085886907bc19c735d700353"18829STANDARDimages/logos/Naccme logo.png2012-05-10T19:46:22.000Z"048fd5f84a676208fdeeebc69b5ab68a"21807STANDARDimages/logos/OLN BO stacked sized.jpg2012-02-03T15:23:15.000Z"0c3d1898c13a707704fda58f2c8397f9"27964STANDARDimages/logos/OLN stacked 258x116.jpg2012-02-03T19:18:44.000Z"54ed338186ca9a61bb59203293c7b89d"34416STANDARDimages/logos/Philly pic.jpg2012-03-01T21:29:51.000Z"ff0dd0380a508a5084b5bf836148f92e"212806STANDARDimages/logos/SAWC big reg sized.jpg2012-02-16T21:13:27.000Z"38c1e2d62af1fab3f952707866fb81c4"26460STANDARDimages/logos/SAWC color reg Sized.jpg2012-02-03T14:18:36.000Z"1f1db88749f09bc7a671f7bdcfb12a0e"23816STANDARDimages/logos/SAWC just logo sized.jpg2012-02-16T17:40:06.000Z"2b00786648a5beaabfae53ed264f6cca"21007STANDARDimages/logos/SAWC just logo.jpg2012-02-16T17:13:41.000Z"005cef037c5d1718386878e1ab85bc27"17416STANDARDimages/logos/SAWC new banner.png2012-04-02T18:43:47.000Z"699f1b350ff627e88f81bffe30ceac5f"70508STANDARDimages/logos/SAWC text.jpg2012-02-16T17:40:45.000Z"0016923e06926adfb4f9ba0ab7558057"12594STANDARDimages/logos/Salix Logo.jpg2012-05-09T13:51:17.000Z"84294768ebdb72c04c225355355c28ea"37583STANDARDimages/logos/Screen Shot 2012-03-08 at 12.27.58 PM.png2012-03-08T17:29:54.000Z"a605bb26ad31ddf359d0feec162b830b"197399STANDARDimages/logos/Screen Shot 2012-03-08 at 3.02.49 PM.png2012-03-08T20:03:16.000Z"051aeb895eaa433022f9ac53e97c804b"45419STANDARDimages/logos/acist_sm.jpg2011-12-13T16:42:18.000Z"7df7aaf64dc603c070beff458a9d18a8"5963STANDARDimages/logos/aorn_59_sm.jpg2012-03-06T17:44:10.000Z"424a94fda7c20477cbc38a86571eb8da"7383STANDARDimages/logos/bio_healing_sm.jpg2012-04-19T21:15:48.000Z"a33a72291ea88741c424824becf9a54b"20218STANDARDimages/logos/biohealing_sm.jpg2011-12-15T21:20:20.000Z"0d03252bc17fbdee532018f247d3dd75"3003STANDARDimages/logos/bsn_med_sm.jpg2012-04-19T21:15:48.000Z"13aa2e3a46ef0be86da4ee4479d20bf9"7435STANDARDimages/logos/bwebster_tag.jpg2011-11-28T18:45:43.000Z"c3c9d38f2cbb13692cf5abf67325add3"10742STANDARDimages/logos/cflc_color_sm.jpg2012-03-30T18:01:18.000Z"6095e904b05868c7542a8f74fe96aacd"39991STANDARDimages/logos/cflc_sm.jpg2012-01-25T16:11:19.000Z"feda6beb8cf4766ce1c087eb6b6ec0bc"6143STANDARDimages/logos/cincinnati_sm.gif2012-01-03T14:29:28.000Z"9d518dd6495685248611bde368dab7ad"1855STANDARDimages/logos/cmellc_naccme_sm.jpg2012-05-03T14:54:30.000Z"fb606b1ccd7c1ca475f9ca7ad1d441e2"13779STANDARDimages/logos/consultant_pediatric.jpg2012-03-12T20:06:53.000Z"6bf8fea645fa25c0481f2207d49325ab"562376STANDARDimages/logos/consultant_sm.jpg2012-03-28T16:52:41.000Z"860ed3783bb17e022ccf0d1ba48786e1"12014STANDARDimages/logos/core_med.jpg2012-01-12T17:28:48.000Z"edb905f911599a2e59a47a997e117fab"14794STANDARDimages/logos/core_sm.jpg2012-01-12T18:26:37.000Z"d94377f8cbf3d5eb57adcb35a5b28d6c"15087STANDARDimages/logos/cpe_dietitian.jpg2011-11-15T19:50:37.000Z"dee91d0a4c0a2b10636f818953930030"5700STANDARDimages/logos/cvln_reg_lg.jpg2011-12-13T16:52:36.000Z"5a1de6c6919dece378a98163cdd07c16"17121STANDARDimages/logos/cvln_reg_sm.jpg2012-02-07T20:47:46.000Z"17d49aa07282a5916c086f8d846c7387"9019STANDARDimages/logos/cvln_sm.jpg2011-11-10T16:07:30.000Z"8a1987509d5dec624a0e008f207eff5f"9453STANDARDimages/logos/cvln_tag_reg_lg.jpg2012-02-22T19:11:40.000Z"58906667fdb3c8460d60a0331f270300"38120STANDARDimages/logos/cvln_tag_reg_med.jpg2011-11-28T18:45:44.000Z"5d03f02b59af2331504446e2cf3c91c6"17554STANDARDimages/logos/derma_sm.jpg2012-04-20T19:23:02.000Z"0a5db5a883e3056c9de62fc573a232b4"9573STANDARDimages/logos/healthpoint_sm.jpg2012-03-22T19:53:13.000Z"13c69027929c1f5650c9cc087fe6dff0"11780STANDARDimages/logos/horizon_sm.gif2011-11-22T19:57:27.000Z"4a7276f9012f8b2c513c8feee011049b"1954STANDARDimages/logos/johnshop_sm.jpg2012-02-29T18:06:56.000Z"c7858b69663ca973422f85ae30ef6410"3280STANDARDimages/logos/mcln_boxed_sized_alpha.png2012-03-08T21:12:22.000Z"776d4cf1b63de5127969bca475008b32"15491STANDARDimages/logos/mcln_notag_sm.jpg2011-11-10T16:07:31.000Z"c1314ac1cf1de27219063cc9ee527473"8128STANDARDimages/logos/mcln_tag_sm.jpg2011-11-10T16:07:32.000Z"303fa63e5a1395cfe42746e9271c85c3"7545STANDARDimages/logos/mimedx_sm.gif2012-04-19T15:34:42.000Z"9300329d57f8659a7a92c323a65c8f07"3179STANDARDimages/logos/naccme_med.jpg2011-11-16T00:43:37.000Z"408664b56431d9b177fa7eaf81b3ecb5"10763STANDARDimages/logos/naccme_sm.jpg2011-11-10T16:07:33.000Z"fc19b2c107819094886ab6915752b383"5978STANDARDimages/logos/ncqa_sm.jpg2011-11-23T19:12:59.000Z"92b41264073eb838fb951dcef8faf9a9"36627STANDARDimages/logos/nih_sm.jpg2012-02-29T18:06:56.000Z"c6de17625f9a9e262f0f18b737ba0ac5"5523STANDARDimages/logos/odyssey.jpg2011-11-28T18:45:44.000Z"068320f46535d7888551025899ef52c3"6420STANDARDimages/logos/organo_sm.jpg2012-04-19T21:15:50.000Z"f17ff0e492719e14c3183606ab836309"16134STANDARDimages/logos/pln_logo_enews_sm.jpg2012-01-06T16:48:21.000Z"fa91746e6ccd29ba292615910d9291c1"10552STANDARDimages/logos/pln_tag_sm.jpg2011-11-10T16:07:33.000Z"fa91746e6ccd29ba292615910d9291c1"10552STANDARDimages/logos/pln_white_sm.jpg2011-11-11T17:43:08.000Z"1d56db89268917ed2eedbadc47f4e432"17478STANDARDimages/logos/sawc_sm.jpg2012-03-22T19:32:42.000Z"ecde2d1cede29ca61d366fe0e1eb3a95"11205STANDARDimages/logos/southlake_sm.jpg2011-11-28T19:03:31.000Z"b9c96c82058f94df66cc965c60a3113a"7337STANDARDimages/logos/systagenix.png2012-02-16T17:59:39.000Z"765e7174fd41cdd97ef43149df5c8c06"7607STANDARDimages/logos/tct_sm.jpg2011-11-10T16:07:34.000Z"d674558cde183f41b212241fb4226d15"8171STANDARDimages/logos/vha_sm.jpg2011-11-22T19:57:28.000Z"4a060bb207e7c85f2b61f800bd13a44c"8909STANDARDimages/pln/2011-11-10T19:08:11.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/pln/PLN_Oncology_Image.jpg2011-11-11T18:24:11.000Z"566bf3bc2485c3869afade3395277804"12448371STANDARDimages/pln/PLN_social_email.html2012-01-31T21:29:35.000Z"fe85e6b6b0f483b1be13da58e4b55446"985STANDARDimages/pln/email/2011-11-10T19:08:27.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/pln/email/PLN logo.png2012-02-01T15:04:22.000Z"c327c102fbeb2a1772471d839fb9a459"24122STANDARDimages/pln/email/PLN solo logo.png2012-02-27T18:00:50.000Z"e69f8bd9dd6dea4158c3a83003665246"11243STANDARDimages/pln/email/PLN solo logo.xcf2012-02-27T18:00:14.000Z"d1e5fe3eb32dfe371988128ec97e1a40"52003STANDARDimages/pln/email/PLN_600x100_email.jpg2011-11-10T19:12:32.000Z"dc19c0b0ea1eb9dd9e75737542060d09"76795STANDARDimages/pln/email/Pain Mgmt--Invite.png2012-02-27T18:21:31.000Z"135ec57287c30426acebf1370bf19e5e"477999STANDARDimages/pln/email/pln_2011/2011-11-10T19:13:47.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDimages/pln/email/pln_2011/advandx.jpg2011-11-10T19:19:19.000Z"42d5453bc1c077acf0348597c52e7e79"3851STANDARDimages/pln/email/pln_2011/american.jpg2011-11-10T19:16:14.000Z"01c231e569b66c95e9885ab7a3e8bf19"14923STANDARDimages/pln/email/pln_2011/exp.jpg2011-11-10T19:16:16.000Z"02941b21cfc4191ddb3204db39ed4b62"10784STANDARDimages/pln/email/pln_2011/forest.jpg2011-11-10T19:16:16.000Z"f471c8d43dec964ee1a7e5e799f7e6cc"25509STANDARDimages/pln/email/pln_2011/janssen.jpg2011-11-10T19:16:17.000Z"698b706ae74dc32f93d74ede7fdea97a"7668STANDARDimages/pln/email/pln_2011/merck.jpg2011-11-10T19:16:18.000Z"432e252fa05c32b7da90d08d89043fce"12892STANDARDimages/pln/email/pln_2011/novartis.jpg2011-11-10T19:16:19.000Z"7da0aa4c1405396107f7ad8085977606"18506STANDARDimages/pln/email/pln_2011/otsuka.jpg2011-11-10T19:16:19.000Z"3fcabbac5e8659da393ed4910c559b79"3334STANDARDimages/pln/email/pln_2011/pfizer.jpg2011-11-10T19:16:20.000Z"2919dbac19fedfd47d8f9eff76f08c24"10381STANDARDimages/pln/email/pln_2011/pharmedium.jpg2011-11-10T19:16:21.000Z"04de6690e0d6a978b1f875f3083be630"14872STANDARDimages/pln/email/pln_2011/pln_atlanta2011_agenda.jpg2011-11-10T19:14:00.000Z"94267d741a4b092fa9ccd327a33b5226"90863STANDARDimages/pln/email/pln_2011/precision.jpg2011-11-10T19:16:22.000Z"38c95dfc566636698a1028671882baee"14470STANDARDimages/pln/email/pln_2011/sagent.jpg2011-11-10T19:16:23.000Z"afc9644b7472f219be1c5e7263883f1d"16885STANDARDimages/pln/email/pln_2011/salix.jpg2011-11-10T19:19:40.000Z"6a2efb277a493b3be425cda096344230"7164STANDARDimages/pln/email/pln_2011/zymo.jpg2011-11-10T19:16:26.000Z"738609e4dad53914c4f794bd8f92c37c"14326STANDARDimages/pln/pln_reg_now.jpg2012-01-30T18:49:57.000Z"480b20ae80d9e9199140a6afc1ef2745"4648STANDARDimages/pln/pln_slides_btn.jpg2012-04-05T14:54:55.000Z"64bbe0842020f855c32e0a98c620539d"3282STANDARDimages/pln/pln_social_bar.gif2012-01-31T21:30:14.000Z"a4f4bbe0377015c9fffdb0715dea0f67"6114STANDARDpc-150x100.jpg2012-05-02T23:37:50.000Z"d9045d33fdf854ba126902f0f98eb1d6"8758STANDARDpc2-150x100.jpg2012-05-02T23:37:51.000Z"90a91b041fc5f69eb15f0bf477b007d7"11431STANDARDpdf/2011-10-05T16:43:53.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/117_2_CVD_FR_CECity.pdf2011-11-11T14:56:29.000Z"790993d17475b9eac29486ff788cff63"277194STANDARDpdf/117_3_Nurse_Certificate.pdf2011-11-11T14:56:30.000Z"3b7a3d664f6a2ef8fbc99a70792c17e4"173374STANDARDpdf/2006-169-2_OAB_ref.pdf2011-11-11T14:56:32.000Z"ac08b646f48f24d5ff30f97c8274170c"73862STANDARDpdf/2006-191-1_ADHD_ref.pdf2011-11-11T14:56:32.000Z"34a523966e56994d7b31f076bc0d56af"47416STANDARDpdf/2006-195-2_Fungal_ref.pdf2011-11-11T14:56:33.000Z"4e16f7e83400b51660c485b4c1b4ae1e"70981STANDARDpdf/2006_152_AAPA.pdf2011-11-11T14:56:31.000Z"32c803c4caf0968a92318ec46b733967"69801STANDARDpdf/2006_152_Nurse.pdf2011-11-11T14:56:31.000Z"343ddc66d68ff44337575e0dcc104888"192644STANDARDpdf/2007-207-1_archived.pdf2011-11-11T14:56:34.000Z"f7fe384a5053a8717603c7cfdfcd308f"1338007STANDARDpdf/2007-216-1-Fall.pdf2011-11-11T14:56:34.000Z"459582d8a32f7c50e90dabf6903ec806"1310894STANDARDpdf/2007_209_web.pdf2011-11-11T14:56:33.000Z"13746da88a81e933afd2beff11a8d917"279390STANDARDpdf/216-2_web_arch.pdf2011-11-11T14:56:30.000Z"a3818153c9c6c51272bf04ee54bd5955"1427307STANDARDpdf/AAPA_Depression and Anxiety Disorders.pdf2011-11-11T14:56:34.000Z"c24dbaf4b24e2ef5a4cb3d58e877f39a"69573STANDARDpdf/AF_Patient_Toolkit.pdf2011-11-23T15:57:25.000Z"0fb279cdcd0771aac1f6abefd5ab5fdb"932546STANDARDpdf/CARDIOaudioweb.pdf2011-11-11T14:56:35.000Z"be461bd11d74d2281648340a2e8e1f46"288826STANDARDpdf/CORE_ACR_Update_01_10_12.pdf2012-02-13T20:21:52.000Z"dc9aae7d6cd35165f34265ef2c665a07"1027700STANDARDpdf/CSWS11_2004.pdf2011-11-11T14:56:43.000Z"90a1498005bdd5177bd56b6f830ab22b"55803STANDARDpdf/CSWS_Scoring_1_2004.pdf2011-11-11T14:56:43.000Z"8294f8de83f7b033271ceba3e298c170"20609STANDARDpdf/List_of_Accepted_2011_Posters.pdf2011-11-11T14:56:44.000Z"9a5cfe1bb4792db5433b3adb3a75765d"64464STANDARDpdf/MCC_FR_Subscription.pdf2011-11-11T14:56:48.000Z"830e33974fbfff831ea6960c365e3781"208656STANDARDpdf/Management_of_OAB_References.pdf2011-11-11T14:56:48.000Z"849ea87e1662409405f4631ab84f30d0"63203STANDARDpdf/McGuirePompeo_SAWC_FINAL_4.20.12.pdf2012-04-20T15:19:59.000Z"333b9c0130ed91f138ad8b4a5448b31a"773845STANDARDpdf/MiMedx_FINAL_BOOKLET.pdf2012-04-25T13:14:24.000Z"4b5ed90f60687c28926a653ec9fee89f"983888STANDARDpdf/Nurse_Depression and Anxiety Disorders.pdf2011-11-11T14:56:55.000Z"df6242368d13beb52a9b8543141508a5"192416STANDARDpdf/Optimal_treatment_strategies_for_patients_with_AF_2011.pdf2011-11-23T15:59:51.000Z"142ba93d308d94365f223f0a8322f9f0"928428STANDARDpdf/Pharmacist_VTE_Cancer.pdf2011-11-11T14:56:55.000Z"ca44edfae5454118425699498ab1b407"34875STANDARDpdf/RAPPS_Outcomes_1 26 2011.pdf2012-02-13T20:21:41.000Z"fba256bf1a52cd9e4d0d5b4b83b139d5"1825357STANDARDpdf/SAWC_Accepted_Oral_Abstract_2011.pdf2011-11-11T14:59:54.000Z"f255f06d49a7cb9ea53f29d79bc97080"34622STANDARDpdf/Stemiv7.pdf2011-11-11T14:59:54.000Z"f9e95e86dff0b13bd932c659799897cf"1313614STANDARDpdf/TOC_April.pdf2011-11-11T14:59:55.000Z"8d0477100aeb48673b41e10e66f2ae1f"386650STANDARDpdf/cathlabbasics/2011-11-11T14:56:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/cathlabbasics/01_OCT.pdf2011-11-11T14:56:35.000Z"9056534a8606705bfd29bf67fa881ed3"1095372STANDARDpdf/cathlabbasics/02_IVUS.pdf2011-11-11T14:56:36.000Z"ce3b0d48ab62d1599278fb976340627e"2210509STANDARDpdf/cathlabbasics/03_CIN.pdf2011-11-11T14:56:36.000Z"771c391f43cfb8971b0a46e7ffa58500"952105STANDARDpdf/cathlabbasics/04_RadialvFemoral.pdf2011-11-11T14:56:36.000Z"eb1eff9944379b6d6451015741c1b71d"1424365STANDARDpdf/cathlabbasics/05_HemodynamicAssist.pdf2011-11-11T14:56:37.000Z"f85945cfe468f560b86bee02483e3e60"518591STANDARDpdf/cathlabbasics/Atlanta2011/2011-11-11T14:56:37.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/cathlabbasics/Atlanta2011/01_CIN.pdf2011-11-11T14:56:37.000Z"b09567acef04c038b9255bc055d9684d"952326STANDARDpdf/cathlabbasics/Atlanta2011/02_OCT.pdf2011-11-11T14:56:38.000Z"4857d3fd24eb180ddfc3ad21fdef2250"1095987STANDARDpdf/cathlabbasics/Atlanta2011/03_IVUS.pdf2011-11-11T14:56:38.000Z"498fdd30322c8809e889de2e553eec63"2210540STANDARDpdf/cathlabbasics/Atlanta2011/04_HemodynamicAssist.pdf2011-11-11T14:56:39.000Z"b685c740f49ea44b8806bc3adfc075cd"518562STANDARDpdf/cathlabbasics/Atlanta2011/05_RadialvFemoral.pdf2011-11-11T14:56:39.000Z"320c01af1f63575ee768f3969b8b43a7"1424423STANDARDpdf/cathlabbasics/HemodynamicAssist.pdf2011-11-11T14:56:39.000Z"b1d96b5430522f98bc3fab4095ccfc25"479526STANDARDpdf/cathlabbasics/NJ_CIN.pdf2011-11-11T14:56:39.000Z"5fe46e873f9d7988fd1ed0f614ab5487"629893STANDARDpdf/cathlabbasics/NJ_Hemo.pdf2011-11-11T14:56:40.000Z"9340e4d8c083cabc427e57a325fc9820"480246STANDARDpdf/cathlabbasics/NJ_IVUS.pdf2011-11-11T14:56:40.000Z"38d687b4886ee8085f2806c8c39b8c07"1165287STANDARDpdf/cathlabbasics/NJ_OCT.pdf2011-11-11T14:56:40.000Z"43f4b64d111b85882f5d3d0b609f2379"694712STANDARDpdf/cathlabbasics/NJ_RVF.pdf2011-11-11T14:56:40.000Z"e1d3c081ae4f4a74b1d5bb927e55d9e0"1034681STANDARDpdf/cathlabbasics/oct.pdf2011-11-11T14:56:41.000Z"2d3d6b81f0d4ea0bdb5c6f0e526be1cb"687304STANDARDpdf/core/2011-11-11T14:56:42.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/core/core.pdf2011-11-11T14:56:42.000Z"e0507f03e475223c017a4eb54a7346a2"962036STANDARDpdf/core/core_newsletter_v1.pdf2011-11-11T14:56:43.000Z"7705035a440a0da3f8d50960f9fa3a3e"423244STANDARDpdf/liveevents/2011-11-11T14:56:44.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/liveevents/35.pdf2011-11-11T14:56:45.000Z"a88e25639753452c3dda6caaba637bf9"716877STANDARDpdf/liveevents/HeartburnTeleBooklet.pdf2011-11-11T14:56:45.000Z"17719e8afb0f970d3aed882b6ca5b040"667151STANDARDpdf/liveevents/Hyponatremia_Nurses.pdf2011-11-11T14:56:45.000Z"9c5ae70a65ae05777b6283ce76484665"472624STANDARDpdf/liveevents/TeleBooklet_Hypo.pdf2011-11-11T14:56:46.000Z"192168d7a13f883949ac7cdcb6769a30"2035355STANDARDpdf/liveevents/Tele_Booklet_Heparins.pdf2011-11-11T14:56:46.000Z"a31c0cc8ee55a2a3d175f206bb01b7cd"2713052STANDARDpdf/liveevents/pg13_TeleBooklet.pdf2011-11-11T14:56:47.000Z"7c6bf871ed9f8bd3252d81648eb75cca"49009STANDARDpdf/mccfr/2011-11-11T14:56:49.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/mccfr/MCCFR_April07-cvr.pdf2011-11-11T14:56:49.000Z"567e85586fb7ef48bdbcb716d4bb60ac"374555STANDARDpdf/mccfr/MCCFR_August 07-cvr.pdf2011-11-11T14:56:49.000Z"d9b60645f206f5efb10f441565373921"133368STANDARDpdf/mccfr/MCCFR_Feb07-cover.pdf2011-11-11T14:56:50.000Z"9e11ed7fa93c021a642a384cd493df24"136226STANDARDpdf/mccfr/MCCFR_Jan07-cover.pdf2011-11-11T14:56:50.000Z"fcf68503f05fc2f20f4442e2ac4f048c"135525STANDARDpdf/mccfr/MCCFR_July 07_cvr.pdf2011-11-11T14:56:50.000Z"6a276945c46ee7cfb6d49e6f00aabd74"153481STANDARDpdf/mccfr/MCCFR_Oct07l-cover.pdf2011-11-11T14:56:51.000Z"f3f9c72eca54745e5bf89c62aa170e8b"133846STANDARDpdf/mccfr/MCCFR_Sept 07-final-cvr.pdf2011-11-11T14:56:51.000Z"1aa10e104b4c5495fb9f029961177149"134599STANDARDpdf/mccfr/_may07_1.pdf2011-11-11T14:56:52.000Z"f4e1d7a613cdc3694318ffab9585334e"65536STANDARDpdf/mccfr/mccfr-nov-cvr.pdf2011-11-11T14:56:51.000Z"94e077e5ddc38aa6ad87a785a63a3143"122370STANDARDpdf/mccfr/mccfr_december_cover.pdf2011-11-11T14:56:51.000Z"53b1aa22f70bb6cb379fc78d5e9b3154"129112STANDARDpdf/mccfr/mccfr_june07-cover.pdf2011-11-11T14:56:52.000Z"745241666dbe2b6115ba35779cd342b0"134174STANDARDpdf/mccfr/mccfr_may07_1.pdf2011-11-11T14:56:52.000Z"1edd7b51f3a83a5adcad89cd535ff66c"77801STANDARDpdf/mccfr/mccfr_may07_2.pdf2011-11-11T14:56:52.000Z"757453fe284817a29422d75161039ed7"64752STANDARDpdf/mccfr/mccfr_may_07_cover.pdf2011-11-11T14:56:52.000Z"b810ca2166e100fac7e8de43a9f01ba0"123051STANDARDpdf/misc/2011-11-11T14:56:54.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/misc/CORE_Intro.pdf2011-11-11T14:56:54.000Z"32b37a9c3f4fb34c46f9c7d196930796"147720STANDARDpdf/misc/testimonials.pdf2011-11-11T14:56:54.000Z"64dd9762e248fe714ed1b66a88b797c1"200054STANDARDpdf/pdf/2011-11-10T21:30:12.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/press_releases/2011-11-18T16:56:26.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/press_releases/Educational_Initiative_Arms_Dental_Professionals_In_Fight.pdf2011-11-18T16:57:07.000Z"2195a15c87c610fb26ae166a13e87d91"54684STANDARDpdf/press_releases/Pharmacy_Learning_Network_VHA_And_Pharmacy_Quality.pdf2011-11-18T16:57:06.000Z"9ea73cf23ce3305ca53b2876cc37f9f1"59957STANDARDpdf/press_releases/State_of_Georgia_Proclaims_April_2012.pdf2011-11-18T16:57:06.000Z"44b5ad83b28036464976e5c0052585f6"58435STANDARDpdf/programs/2011-10-05T16:44:09.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDpdf/programs/01-04.pdf2011-11-01T15:13:39.000Z"be4cb719944b0b797d234982bd0512ea"58743STANDARDpdf/programs/02-03.pdf2011-11-01T15:13:39.000Z"63007dddf6efc76b486a9ae13a5a4c83"179762STANDARDpdf/programs/02-04.pdf2011-11-01T15:13:39.000Z"a0c9c5a7aa79902337725380a3e45629"50286STANDARDpdf/programs/02-05.pdf2011-11-01T15:13:39.000Z"2cb8a0da6ec10ac7bd8e686d4c17bd6e"59717STANDARDpdf/programs/04-04.pdf2011-11-01T15:13:39.000Z"0cc159293be29d94ecdc1c5e35970f39"60939STANDARDpdf/programs/06-04.pdf2011-11-01T15:13:39.000Z"07eaf2d5b8e18d4c00366e92de7f37ec"94304STANDARDpdf/programs/07-03.pdf2011-11-01T15:13:39.000Z"6dff6f8da59b3d3b241ff3d91ab2f206"54868STANDARDpdf/programs/07-04.pdf2011-11-01T15:13:40.000Z"ea40c0fc3e4b7522e98a027f09dac17e"58269STANDARDpdf/programs/07-06.pdf2011-11-01T15:13:40.000Z"4587bbb310a7845e1cd689fa71b1e94b"90963STANDARDpdf/programs/11-03.pdf2011-11-01T15:13:40.000Z"7812b452aed3e198babc216948454621"50635STANDARDpdf/programs/12-02.pdf2011-11-01T15:13:40.000Z"ec1f3bfdb873195a353c7750fe1bde23"18226STANDARDpdf/programs/2003-71-2.pdf2011-11-01T15:13:40.000Z"d27c780958bcc8c4ac1ac7969f34b530"563686STANDARDpdf/programs/2004-07-PE.pdf2011-11-01T15:13:40.000Z"a2ad8318d5846e7cd02f2d1ee93ddd39"58269STANDARDpdf/programs/2004-104.pdf2011-11-01T15:13:42.000Z"26fa6971b4b3df719f54bc3d600df7f4"275552STANDARDpdf/programs/2004-109.pdf2011-11-01T15:13:43.000Z"47b169ce7822d18ed91a6e0759e074bc"332104STANDARDpdf/programs/2004-124.pdf2011-11-01T15:13:43.000Z"39dd86064812d74dc8c56fd42bc89ebf"344300STANDARDpdf/programs/2004-71-5.pdf2011-11-01T15:13:40.000Z"0b67e8b05b2fd5bdd0bf9ed7d9e40cfe"852677STANDARDpdf/programs/2004-71-6.pdf2011-11-01T15:13:41.000Z"af0c8adf9457a301b3d7409c9d910a5a"804552STANDARDpdf/programs/2004-88-2.pdf2011-11-01T15:13:42.000Z"d635a6e4fd98377a75eb9b363567e315"655051STANDARDpdf/programs/2004-99.pdf2011-11-01T15:13:42.000Z"13ff927a38d5d29e4850434abb755320"267632STANDARDpdf/programs/2005-02-PE.pdf2011-11-01T15:13:43.000Z"c29d18763d2080475e71b2729f479308"61986STANDARDpdf/programs/2005-111-1.pdf2011-11-01T15:13:43.000Z"2436cd9149cabba6215edc772897e6d0"342689STANDARDpdf/programs/2005-111-2.pdf2011-11-01T15:13:43.000Z"a7b18b10e2b34fce88bbfd00a0baee07"300577STANDARDpdf/programs/2005-112.pdf2011-11-01T15:13:44.000Z"796bd35426728e68bb72ab45709bcaaf"305209STANDARDpdf/programs/2005-112_Refs.pdf2011-11-01T15:13:44.000Z"23eef92d1acb08cdc0bfda25e26bef0e"57758STANDARDpdf/programs/2005-113.pdf2011-11-01T15:13:44.000Z"b75963fb16aa677c2438d910dc4fcffc"256495STANDARDpdf/programs/2005-114.pdf2011-11-01T15:13:44.000Z"e54d1e16b26364b7ec5f9375bbfd9ef0"567767STANDARDpdf/programs/2005-116.pdf2011-11-01T15:13:45.000Z"d26c0eff4bacca29965f5eb9fb3002b1"478322STANDARDpdf/programs/2005-117-1.pdf2011-11-01T15:13:45.000Z"5ebeba4f8859a983b3dc203cb32120a3"636955STANDARDpdf/programs/2005-117-2.pdf2011-11-01T15:13:46.000Z"6500373754ba77f44fe9806d34c67112"311534STANDARDpdf/programs/2005-117-3.pdf2011-11-01T15:13:46.000Z"62e92dddda222eb01b65aabdb687f76d"978398STANDARDpdf/programs/2005-117.pdf2011-11-01T15:13:45.000Z"d1f73fb0bba9a93c269b078634d44bee"300672STANDARDpdf/programs/2005-118.pdf2011-11-01T15:13:47.000Z"e629d541f691b842b2b2dc9ef0e93b10"1229916STANDARDpdf/programs/2005-119-5.pdf2011-11-01T15:13:48.000Z"af193f2af16090566735fedc1b7ca9fd"494345STANDARDpdf/programs/2005-119-6.pdf2011-11-01T15:13:48.000Z"c6faa8b71d2a8826b9028e7d8430886c"475527STANDARDpdf/programs/2005-120.pdf2011-11-01T15:13:48.000Z"61ee59f53af59febb41c09adab65b146"1141817STANDARDpdf/programs/2005-121-1.pdf2011-11-01T15:13:49.000Z"4ac5241e014bd71f09aea83be7c61abe"510151STANDARDpdf/programs/2005-121-2.pdf2011-11-01T15:13:49.000Z"68338c041c8b80453597a17dff2ca536"281586STANDARDpdf/programs/2005-123.pdf2011-11-01T15:13:50.000Z"0135bc0673a8f9c22fd9c9b60c7653b3"393102STANDARDpdf/programs/2005-124.pdf2011-11-01T15:13:50.000Z"39dd86064812d74dc8c56fd42bc89ebf"344300STANDARDpdf/programs/2005-125.pdf2011-11-01T15:13:50.000Z"a708b6d348f6a2dafdcb1ab62a378a49"244484STANDARDpdf/programs/2005-129.pdf2011-11-01T15:13:50.000Z"1dc6628ca872a3c23f84c37f5725bed2"365115STANDARDpdf/programs/2005-132.pdf2011-11-01T15:13:51.000Z"72081d785f85e94926ed1841a07ec990"366401STANDARDpdf/programs/2005-137.pdf2011-11-01T15:13:51.000Z"3b78b307622a6cf05c351b18741f66b6"184555STANDARDpdf/programs/2005-138.pdf2011-11-01T15:13:51.000Z"644a4e4774d367e1635391e5145eba1e"300590STANDARDpdf/programs/2005-139.pdf2011-11-01T15:13:51.000Z"a1847a8689eab7fef93ecd75885e3184"130203STANDARDpdf/programs/2005-140.pdf2011-11-01T15:13:51.000Z"6136bcd8a51a98d11f3968686233eed5"417558STANDARDpdf/programs/2005-141.pdf2011-11-01T15:13:52.000Z"5f87bdd5c76b2edb2c2c1313e0a879e7"322575STANDARDpdf/programs/2005-143.pdf2011-11-01T15:13:52.000Z"147aa2a88b8b20af4cd95a6feacf726f"297525STANDARDpdf/programs/2005-145.pdf2011-11-01T15:13:52.000Z"922aac9a5af0a6edb8615bde361dc326"285355STANDARDpdf/programs/2005-149.pdf2011-11-01T15:13:52.000Z"0d7e6a38d1d27fa85f5b37e8a4d3fe3b"638057STANDARDpdf/programs/2006-135.pdf2011-11-01T15:13:53.000Z"02487b7154003155c1c09d8d5ee7f9b4"339778STANDARDpdf/programs/2006-136.pdf2011-11-01T15:13:53.000Z"fe5e588fa55aeee4344419b89080bd74"437769STANDARDpdf/programs/2006-142.pdf2011-11-01T15:13:53.000Z"5a73b3351e4d491f8384bbf3c2921313"463969STANDARDpdf/programs/2006-146-1.pdf2011-11-01T15:13:54.000Z"19b30030d4a65ab4a9b08d93908ad53c"513624STANDARDpdf/programs/2006-146-2.pdf2011-11-01T15:13:54.000Z"527d108cabebc93f073aa46618e626a0"299251STANDARDpdf/programs/2006-146-3.pdf2011-11-01T15:13:54.000Z"a47ec49c1d7542bd9d4e331244a91be8"304540STANDARDpdf/programs/2006-147.pdf2011-11-01T15:13:55.000Z"30a169835059f44c748dd883858aab54"332182STANDARDpdf/programs/2006-150.pdf2011-11-01T15:13:55.000Z"2e88dc9594f423ef42352ffb73a7e55f"459570STANDARDpdf/programs/2006-151.pdf2011-11-01T15:13:55.000Z"72888465b494f0efc57d4d4934c12f7d"331089STANDARDpdf/programs/2006-152.pdf2011-11-01T15:13:55.000Z"af23008072535534fabf48c00ba76920"478123STANDARDpdf/programs/2006-153-1.pdf2011-11-01T15:13:56.000Z"08426926ebb239a948d97a3e459d266e"368462STANDARDpdf/programs/2006-153-2.pdf2011-11-01T15:13:56.000Z"b398d3e534da3b8b24635f1d2338aa1b"514375STANDARDpdf/programs/2006-153-3.pdf2011-11-01T15:13:56.000Z"72cb4b78226cc6e0bb6f48e3c2e02833"270898STANDARDpdf/programs/2006-153-4.pdf2011-11-01T15:13:57.000Z"8aeb1ef06ee6fbadad9c43d251b7957e"273817STANDARDpdf/programs/2006-154.pdf2011-11-01T15:13:57.000Z"4a05ff18c01ed96bc8de0c36145a3919"823968STANDARDpdf/programs/2006-155.pdf2011-11-01T15:13:57.000Z"0dde34674d45437147f8b62b7a8a8d80"754674STANDARDpdf/programs/2006-156.pdf2011-11-01T15:13:58.000Z"164a559049d7fbf7b884743190fb05df"293737STANDARDpdf/programs/2006-157.pdf2011-11-01T15:13:58.000Z"e02fb9ab8126b110edc0c4154864c9fb"429273STANDARDpdf/programs/2006-158.pdf2011-11-01T15:13:59.000Z"c034681bd6d10865737a6c5964a7d901"260828STANDARDpdf/programs/2006-161-1.pdf2011-11-01T15:13:59.000Z"6683973bea329b57fdf77aa21b5302fd"340884STANDARDpdf/programs/2006-161-2.pdf2011-11-01T15:13:59.000Z"2415e801a02755f6826ef7702e830ad3"463390STANDARDpdf/programs/2006-162.pdf2011-11-01T15:13:59.000Z"45f186fc19cef443cc24160efdc4366d"276541STANDARDpdf/programs/2006-163.pdf2011-11-01T15:14:00.000Z"674103c02fd577e1cedf60400917debf"360178STANDARDpdf/programs/2006-164.pdf2011-11-01T15:14:00.000Z"3555b61c35e03afb8bc1a7c762abd579"701667STANDARDpdf/programs/2006-165-1.pdf2011-11-01T15:14:00.000Z"5665edd647ce6c742836e3ed9fb8253c"395401STANDARDpdf/programs/2006-165-2.pdf2011-11-01T15:14:01.000Z"8fdcd839986d29f3c99161a9455de49d"529534STANDARDpdf/programs/2006-166-1.pdf2011-11-01T15:14:01.000Z"6d6c1d1042a39d5d72063d66e0cbdd32"305725STANDARDpdf/programs/2006-166-2.pdf2011-11-01T15:14:01.000Z"c7edfec4cef3b8f58b35ba9b1f85408a"329945STANDARDpdf/programs/2006-167.pdf2011-11-01T15:14:01.000Z"e7f34cd1cf9127bfb513265ca5aa84e5"332755STANDARDpdf/programs/2006-168.pdf2011-11-01T15:14:02.000Z"03ad386440520dc2d7c4583c086dfb04"745458STANDARDpdf/programs/2006-169-1.pdf2011-11-01T15:14:02.000Z"731efefd4dbe13028950814a1eb9bf34"405656STANDARDpdf/programs/2006-169-2.pdf2011-11-01T15:14:02.000Z"7a57dc451cc6a90228aaf1e5edb83003"571942STANDARDpdf/programs/2006-170-1.pdf2011-11-01T15:14:03.000Z"ca94cf526d2313b1f3b6adb6610fdb1b"365502STANDARDpdf/programs/2006-170-2.pdf2011-11-01T15:14:03.000Z"532910cd4999a09cc16e0efb54882b8a"493570STANDARDpdf/programs/2006-171-2.pdf2011-11-01T15:14:04.000Z"64108d38bf750d3202cf36378f602076"521274STANDARDpdf/programs/2006-171.pdf2011-11-01T15:14:03.000Z"f845ef8457c8becb2d00ef7ea931a2b7"642125STANDARDpdf/programs/2006-172-1.pdf2011-11-01T15:14:04.000Z"60f5262b25327cba186f505d04cb6a43"605442STANDARDpdf/programs/2006-172-2.pdf2011-11-01T15:14:05.000Z"92901ec887e532bed3a779febc9e2b35"610979STANDARDpdf/programs/2006-173.pdf2011-11-01T15:14:05.000Z"188334d4ca419fcbe38acb4d91e0b922"408482STANDARDpdf/programs/2006-174.pdf2011-11-01T15:14:05.000Z"3ad12ce1e515ecc89708a01c60add907"751756STANDARDpdf/programs/2006-175.pdf2011-11-01T15:14:06.000Z"3e31b284c312e57a7fe4206365db37db"533211STANDARDpdf/programs/2006-177-1.pdf2011-11-01T15:14:07.000Z"08573546e2f76fe6b546f50e444fd885"428779STANDARDpdf/programs/2006-177.pdf2011-11-01T15:14:06.000Z"4be905ecd11d228e65bd28197b8eef14"423406STANDARDpdf/programs/2006-178.pdf2011-11-01T15:14:07.000Z"6d7f75a2693de59c560adf8aa6e2f5f3"460343STANDARDpdf/programs/2006-179.pdf2011-11-01T15:14:07.000Z"116b3a4e6471becba778ee8ee9a00017"937178STANDARDpdf/programs/2006-180.pdf2011-11-01T15:14:08.000Z"b4873c1d70196092418b945eb951ad8e"697443STANDARDpdf/programs/2006-181.pdf2011-11-01T15:14:08.000Z"96b760a267bb204cbde7fdd10b6ec30b"555876STANDARDpdf/programs/2006-183-1.pdf2011-11-01T15:14:09.000Z"393836d2f229f43db888a7899a9d473a"365479STANDARDpdf/programs/2006-183-2.pdf2011-11-01T15:14:09.000Z"6323e7cbe98eb893cd98db150fac81fe"414114STANDARDpdf/programs/2006-185.pdf2011-11-01T15:14:09.000Z"e537177b46af118950f1226cb6216aa1"517944STANDARDpdf/programs/2006-187.pdf2011-11-01T15:14:10.000Z"13dd3868a7223d2bc1d5487671302d6b"644243STANDARDpdf/programs/2006-188.pdf2011-11-01T15:14:10.000Z"bc47e6cdefadc7b24c3c768564e440f2"490079STANDARDpdf/programs/2006-190.pdf2011-11-01T15:14:10.000Z"21b5dbe601cf55d4817245124f5786df"475540STANDARDpdf/programs/2006-191-1.pdf2011-11-01T15:14:11.000Z"2555602bdea9bdfc82dffbbc6795f637"528588STANDARDpdf/programs/2006-194.pdf2011-11-01T15:14:11.000Z"70bdf647fdf92fc9faa8ff5e81d6f693"686081STANDARDpdf/programs/2006-195-1.pdf2011-11-01T15:14:12.000Z"5c3fb330b259e35047f89b198edd6098"556631STANDARDpdf/programs/2006-195-2.pdf2011-11-01T15:14:12.000Z"07b143a758482d8e958cb668242f7460"534089STANDARDpdf/programs/2006-196.pdf2011-11-01T15:14:12.000Z"6fe160774413942142e76d0e1df8575e"617153STANDARDpdf/programs/2006-197-1.pdf2011-11-01T15:14:13.000Z"f277f54daab0bd97e8aa950bd144bdb6"974787STANDARDpdf/programs/2006-197-2.pdf2011-11-01T15:14:13.000Z"55bc89224f5c56b5ed50158d6f34007e"643186STANDARDpdf/programs/2006-198.pdf2011-11-01T15:14:14.000Z"ddeb767aadb123d5716eeba6cb0aa66e"1014635STANDARDpdf/programs/2006-199.pdf2011-11-01T15:14:14.000Z"372c6f072249ce155057816a24386934"341331STANDARDpdf/programs/2006-200.pdf2011-11-01T15:14:14.000Z"8d08c4374b71b3a2b437e4d0895ca2c9"422159STANDARDpdf/programs/2006-201.pdf2011-11-01T15:14:15.000Z"14b0f43a4060aadb2de6c3ad445da9a2"1239055STANDARDpdf/programs/2006-202.pdf2011-11-01T15:14:15.000Z"8b2f7e8f43a442638f4890f01997e947"528041STANDARDpdf/programs/2006-210-1.pdf2011-11-01T15:14:15.000Z"79c71ef2340e12d64b814beb1222e912"1208722STANDARDpdf/programs/2007-184.pdf2011-11-01T15:14:16.000Z"0802354843b53850834fed2c6ba7c5b1"270482STANDARDpdf/programs/2007-189.pdf2011-11-01T15:14:16.000Z"4d032b9ee5a7059bfd9c80b157996481"514015STANDARDpdf/programs/2007-191-2.pdf2011-11-01T15:14:16.000Z"d3421cc108223a5320bbce5b5f66f585"579048STANDARDpdf/programs/2007-192.pdf2011-11-01T15:14:16.000Z"de3bcac3d47f26f6d92d140ddcd94ba1"565757STANDARDpdf/programs/2007-193.pdf2011-11-01T15:14:17.000Z"9f0cd444f573c2d1f5b7b6dbc911c211"701101STANDARDpdf/programs/2007-206.pdf2011-11-01T15:14:17.000Z"e38382d92826042ba6e2fe325232bd0f"295843STANDARDpdf/programs/2007-207-1.pdf2011-11-01T15:14:17.000Z"f7fe384a5053a8717603c7cfdfcd308f"1338007STANDARDpdf/programs/2007-207-2.pdf2011-11-01T15:14:18.000Z"1decce037f70460fb485945acb0a4f95"669756STANDARDpdf/programs/2007-210-2.pdf2011-11-01T15:14:18.000Z"c95df70419e633403ea488bb19a94d59"572727STANDARDpdf/programs/2007-212.pdf2011-11-01T15:14:18.000Z"392699f4b525ebe02d1b0228f747e723"577397STANDARDpdf/programs/2007-213.pdf2011-11-01T15:14:19.000Z"8c407a67b62d57d2cf32f58f2a55b3f1"1119200STANDARDpdf/programs/2007-214-1.pdf2011-11-01T15:14:19.000Z"d33862a7db3774a5678502709ab7329d"1393960STANDARDpdf/programs/2007-214-2.pdf2011-11-01T15:14:19.000Z"4ea30000c8cfe7ad912374d57937b798"552236STANDARDpdf/programs/2007-216-1.pdf2011-11-01T15:14:20.000Z"1e8c4b15e1b2476140b5737a78e27015"1320172STANDARDpdf/programs/2007-216-2.pdf2011-11-01T15:14:20.000Z"a3818153c9c6c51272bf04ee54bd5955"1427307STANDARDpdf/programs/2007-218.pdf2011-11-01T15:14:21.000Z"d58f0d372e02db73e396870c6e07236f"881057STANDARDpdf/programs/2007-222.pdf2011-11-01T15:14:21.000Z"8888a40ec969d33bbb927a5b1106b0ed"1160378STANDARDpdf/programs/2007-223-1.pdf2011-11-01T15:14:22.000Z"9de40619e9265210b7094942731e38af"1091050STANDARDpdf/programs/2007-227.pdf2011-11-01T15:14:22.000Z"59e634b3b5349e9a9d91916fe2d5ba4f"900336STANDARDpdf/programs/2007-230.pdf2011-11-01T15:14:22.000Z"beb1e0f7dce590194129db80e5a34743"912965STANDARDpdf/programs/MCC-FR.pdf2011-11-01T15:14:23.000Z"6543b1d3cb438208ac62babf8951679f"384706STANDARDpdf/programs/report1493.pdf2011-10-05T16:51:30.000Z"c65b0602bcb96f70fbd8c7e01adbe0e5"1341300STANDARDpdf/programs/report1507.pdf2011-10-05T16:44:59.000Z"ee3ef6e62760af67048f1e3726281608"1138983STANDARDpdf/programs/report1508.pdf2011-10-05T16:44:23.000Z"685fde1a2c0bf20deda3d89b40b7d649"1133083STANDARDpdf/programs/report1586.pdf2011-11-14T15:42:49.000Z"b8bc36736acd802b7ad6f2b3a71e3d97"1161743STANDARDpdf/programs/report1587.pdf2011-11-14T15:42:56.000Z"23c3040c02bdd236a4275bfb334d69c1"1328551STANDARDpdf/programs/report311.pdf2011-11-01T15:14:23.000Z"ad2d31ee891448dad9f9fa80fc5b28a5"924764STANDARDpdf/programs/report312.pdf2011-11-01T15:14:23.000Z"46384d8eee90b0572c6967b7dc12decb"28240STANDARDpdf/programs/report314.pdf2011-11-01T15:14:23.000Z"0802354843b53850834fed2c6ba7c5b1"270482STANDARDpdf/programs/report315.pdf2011-11-01T15:14:23.000Z"46384d8eee90b0572c6967b7dc12decb"28240STANDARDpdf/programs/report316.pdf2011-11-01T15:14:23.000Z"4ea30000c8cfe7ad912374d57937b798"552236STANDARDpdf/programs/report317.pdf2011-11-01T15:14:24.000Z"1decce037f70460fb485945acb0a4f95"669756STANDARDpdf/programs/report318.pdf2011-11-01T15:14:24.000Z"8888a40ec969d33bbb927a5b1106b0ed"1160378STANDARDpdf/programs/report319.pdf2011-11-01T15:14:24.000Z"55bc89224f5c56b5ed50158d6f34007e"643186STANDARDpdf/programs/report320.pdf2011-11-01T15:14:25.000Z"4d032b9ee5a7059bfd9c80b157996481"514015STANDARDpdf/programs/report322.pdf2011-11-01T15:14:25.000Z"1e8c4b15e1b2476140b5737a78e27015"1320172STANDARDpdf/programs/report323.pdf2011-11-01T15:14:25.000Z"e38382d92826042ba6e2fe325232bd0f"295843STANDARDpdf/programs/report325.pdf2011-11-01T15:14:26.000Z"8c407a67b62d57d2cf32f58f2a55b3f1"1119200STANDARDpdf/programs/report326.pdf2011-11-01T15:14:26.000Z"4ea30000c8cfe7ad912374d57937b798"552236STANDARDpdf/programs/report327.pdf2011-11-01T15:14:26.000Z"c95df70419e633403ea488bb19a94d59"572727STANDARDpdf/programs/report328.pdf2011-11-01T15:14:26.000Z"0802354843b53850834fed2c6ba7c5b1"270482STANDARDpdf/programs/report329.pdf2011-11-01T15:14:27.000Z"9f0cd444f573c2d1f5b7b6dbc911c211"701101STANDARDpdf/programs/report330.pdf2011-11-01T15:14:27.000Z"ddeb767aadb123d5716eeba6cb0aa66e"1014635STANDARDpdf/programs/report331.pdf2011-11-01T15:14:28.000Z"392699f4b525ebe02d1b0228f747e723"577397STANDARDpdf/programs/report333.pdf2011-11-01T15:14:28.000Z"d33862a7db3774a5678502709ab7329d"1393960STANDARDpdf/programs/report334.pdf2011-11-01T15:14:28.000Z"d3421cc108223a5320bbce5b5f66f585"579048STANDARDpdf/programs/report335.pdf2011-11-01T15:14:28.000Z"79c71ef2340e12d64b814beb1222e912"1208722STANDARDpdf/programs/report336.pdf2011-11-01T15:14:29.000Z"74dd13f1f4c0b7c26fdd5ab4a754b0e3"490619STANDARDpdf/programs/report337.pdf2011-11-01T15:14:29.000Z"de3bcac3d47f26f6d92d140ddcd94ba1"565757STANDARDpdf/programs/report338.pdf2011-11-01T15:14:29.000Z"8aeb1ef06ee6fbadad9c43d251b7957e"273817STANDARDpdf/programs/report339.pdf2011-11-01T15:14:30.000Z"55bc89224f5c56b5ed50158d6f34007e"643186STANDARDpdf/programs/report341.pdf2011-11-01T15:14:30.000Z"7a57dc451cc6a90228aaf1e5edb83003"571942STANDARDpdf/programs/report343.pdf2011-11-01T15:14:30.000Z"6fe160774413942142e76d0e1df8575e"617153STANDARDpdf/programs/report344.pdf2011-11-01T15:14:30.000Z"07b143a758482d8e958cb668242f7460"534089STANDARDpdf/programs/report346.pdf2011-11-01T15:14:31.000Z"2555602bdea9bdfc82dffbbc6795f637"528588STANDARDpdf/programs/report347.pdf2011-11-01T15:14:31.000Z"c7edfec4cef3b8f58b35ba9b1f85408a"329945STANDARDpdf/programs/report348.pdf2011-11-01T15:14:31.000Z"13746da88a81e933afd2beff11a8d917"279390STANDARDpdf/programs/report349.pdf2011-11-01T15:14:31.000Z"14b0f43a4060aadb2de6c3ad445da9a2"1239055STANDARDpdf/programs/report350.pdf2011-11-01T15:14:32.000Z"72cb4b78226cc6e0bb6f48e3c2e02833"270898STANDARDpdf/programs/report351.pdf2011-11-01T15:14:32.000Z"5c3fb330b259e35047f89b198edd6098"556631STANDARDpdf/programs/report352.pdf2011-11-01T15:14:32.000Z"ac72e88bb2ce5575a2b490ebd3371f41"900329STANDARDpdf/programs/report353.pdf2011-11-01T15:14:32.000Z"8d08c4374b71b3a2b437e4d0895ca2c9"422159STANDARDpdf/programs/report354.pdf2011-11-01T15:14:33.000Z"8b2f7e8f43a442638f4890f01997e947"528041STANDARDpdf/programs/report355.pdf2011-11-01T15:14:33.000Z"59e634b3b5349e9a9d91916fe2d5ba4f"900336STANDARDpdf/programs/report356.pdf2011-11-01T15:14:33.000Z"70bdf647fdf92fc9faa8ff5e81d6f693"686081STANDARDpdf/programs/report358.pdf2011-11-01T15:14:33.000Z"bc47e6cdefadc7b24c3c768564e440f2"490079STANDARDpdf/programs/report359.pdf2011-11-01T15:14:34.000Z"372c6f072249ce155057816a24386934"341331STANDARDpdf/programs/report360.pdf2011-11-01T15:14:34.000Z"3e31b284c312e57a7fe4206365db37db"533211STANDARDpdf/programs/report361.pdf2011-11-01T15:14:34.000Z"a3818153c9c6c51272bf04ee54bd5955"1427307STANDARDpdf/programs/report362.pdf2011-11-01T15:14:35.000Z"21b5dbe601cf55d4817245124f5786df"475540STANDARDpdf/programs/report364.pdf2011-11-01T15:14:35.000Z"f277f54daab0bd97e8aa950bd144bdb6"974787STANDARDpdf/programs/report366.pdf2011-11-01T15:14:35.000Z"6323e7cbe98eb893cd98db150fac81fe"414114STANDARDpdf/programs/report367.pdf2011-11-01T15:14:35.000Z"393836d2f229f43db888a7899a9d473a"365479STANDARDpdf/programs/report368.pdf2011-11-01T15:14:36.000Z"60f5262b25327cba186f505d04cb6a43"605442STANDARDpdf/programs/report370.pdf2011-11-01T15:14:36.000Z"116b3a4e6471becba778ee8ee9a00017"937178STANDARDpdf/programs/report372.pdf2011-11-01T15:14:36.000Z"b4873c1d70196092418b945eb951ad8e"697443STANDARDpdf/programs/report373.pdf2011-11-01T15:14:36.000Z"532910cd4999a09cc16e0efb54882b8a"493570STANDARDpdf/programs/report375.pdf2011-11-01T15:14:37.000Z"e537177b46af118950f1226cb6216aa1"517944STANDARDpdf/programs/report376.pdf2011-11-01T15:14:37.000Z"96b760a267bb204cbde7fdd10b6ec30b"555876STANDARDpdf/programs/report378.pdf2011-11-01T15:14:37.000Z"3ad12ce1e515ecc89708a01c60add907"751756STANDARDpdf/programs/report380.pdf2011-11-01T15:14:37.000Z"13dd3868a7223d2bc1d5487671302d6b"644243STANDARDpdf/programs/report381.pdf2011-11-01T15:14:38.000Z"a47ec49c1d7542bd9d4e331244a91be8"304540STANDARDpdf/programs/report382.pdf2011-11-01T15:14:38.000Z"6d6c1d1042a39d5d72063d66e0cbdd32"305725STANDARDpdf/programs/report383.pdf2011-11-01T15:14:38.000Z"08573546e2f76fe6b546f50e444fd885"428779STANDARDpdf/programs/report385.pdf2011-11-01T15:14:38.000Z"188334d4ca419fcbe38acb4d91e0b922"408482STANDARDpdf/programs/report386.pdf2011-11-01T15:14:39.000Z"92901ec887e532bed3a779febc9e2b35"610979STANDARDpdf/programs/report388.pdf2011-11-01T15:14:39.000Z"731efefd4dbe13028950814a1eb9bf34"405656STANDARDpdf/programs/report390.pdf2011-11-01T15:14:39.000Z"fe5e588fa55aeee4344419b89080bd74"437769STANDARDpdf/programs/report391.pdf2011-11-01T15:14:39.000Z"1feca5e455a5f11635066f9d367dd23f"392316STANDARDpdf/programs/report392.pdf2011-11-01T15:14:39.000Z"2415e801a02755f6826ef7702e830ad3"463390STANDARDpdf/programs/report394.pdf2011-11-01T15:14:40.000Z"4be905ecd11d228e65bd28197b8eef14"423406STANDARDpdf/programs/report395.pdf2011-11-01T15:14:40.000Z"ca94cf526d2313b1f3b6adb6610fdb1b"365502STANDARDpdf/programs/report397.pdf2011-11-01T15:14:40.000Z"f845ef8457c8becb2d00ef7ea931a2b7"642125STANDARDpdf/programs/report399.pdf2011-11-01T15:14:40.000Z"64108d38bf750d3202cf36378f602076"521274STANDARDpdf/programs/report401.pdf2011-11-01T15:14:41.000Z"6683973bea329b57fdf77aa21b5302fd"340884STANDARDpdf/programs/report404.pdf2011-11-01T15:14:41.000Z"1decce037f70460fb485945acb0a4f95"669756STANDARDpdf/programs/report405.pdf2011-11-01T15:14:41.000Z"03ad386440520dc2d7c4583c086dfb04"745458STANDARDpdf/programs/report407.pdf2011-11-01T15:14:41.000Z"a3818153c9c6c51272bf04ee54bd5955"1427307STANDARDpdf/programs/report409.pdf2011-11-01T15:14:42.000Z"f7fe384a5053a8717603c7cfdfcd308f"1338007STANDARDpdf/programs/report412.pdf2011-11-01T15:14:42.000Z"63f41284f1d3d53b4ea0641c6c38ddfd"1085902STANDARDpdf/programs/report414.pdf2011-11-01T15:14:43.000Z"bf41cf6fd9ca8ca9cca8fe28e009c4b1"1085465STANDARDpdf/programs/report415.pdf2011-11-01T15:14:43.000Z"f67b43103d5b315cce302500b9ce7e78"1325155STANDARDpdf/programs/report416.pdf2011-11-01T15:14:44.000Z"7b71d1798df1a472cdcb70dac782ab46"46490STANDARDpdf/programs/report417.pdf2011-11-01T15:14:44.000Z"0189f3d0ced8181ef191bfd5af5c9465"927676STANDARDpdf/programs/report418.pdf2011-11-01T15:14:44.000Z"d58f0d372e02db73e396870c6e07236f"881057STANDARDpdf/programs/report421.pdf2011-11-01T15:14:44.000Z"678a05d7576bc18db57ffbacfa671840"444843STANDARDpdf/programs/report423.pdf2011-11-01T15:14:45.000Z"870672267e17e0985a477ad09ffa1799"515485STANDARDpdf/programs/report424.pdf2011-11-01T15:14:45.000Z"484178588faf1b6fc43658bc8df50d3d"645879STANDARDpdf/programs/report426.pdf2011-11-01T15:14:45.000Z"63f41284f1d3d53b4ea0641c6c38ddfd"1085902STANDARDpdf/programs/report427.pdf2011-11-01T15:14:45.000Z"eccce519a774c97abc7718934dbd90b0"533590STANDARDpdf/programs/report429.pdf2011-11-01T15:14:46.000Z"64ac57c3b615c2b991c932361226a0c2"1126339STANDARDpdf/programs/report430.pdf2011-11-01T15:14:46.000Z"0422d78af78da1c713c9164423ed70bb"865704STANDARDpdf/programs/report433.pdf2011-11-01T15:14:46.000Z"0422d78af78da1c713c9164423ed70bb"865704STANDARDpdf/programs/report435.pdf2011-11-01T15:14:47.000Z"66d76fd38b0c55d3a96d64b6a5db12ba"985194STANDARDpdf/programs/report439.pdf2011-11-01T15:14:47.000Z"b923d42293fce6949e96686dfeb98661"51462STANDARDpdf/programs/report440.pdf2011-11-01T15:14:47.000Z"addb97bdd9a6315514947c4f32fc7bdb"46461STANDARDpdf/programs/report451.pdf2011-11-01T15:14:47.000Z"aa0c7025f676280999976d3001fecaaa"1038117STANDARDpdf/programs/report457.pdf2011-11-01T15:14:48.000Z"feb36a06b1f72686b5115589a6624e3a"330618STANDARDpdf/programs/report459.pdf2011-11-01T15:14:48.000Z"e76964b81e826d6cc73d724e65a5dd5e"1076185STANDARDpdf/programs/report460.pdf2011-11-01T15:14:48.000Z"222e092be790a8f2a2a7cafbd490faca"1018658STANDARDpdf/programs/report463.pdf2011-11-01T15:14:49.000Z"77cc409f72c3b58b1af539442c88beb4"184531STANDARDpdf/programs/report466.pdf2011-11-01T15:14:49.000Z"13c81bdbedde18c936a991233c3be606"438411STANDARDpdf/programs/report469.pdf2011-11-01T15:14:49.000Z"aa0c7025f676280999976d3001fecaaa"1038117STANDARDpdf/programs/report471.pdf2011-11-01T15:14:49.000Z"2ee5019554547164f3aa58c902692c4b"1061108STANDARDpdf/programs/report473.pdf2011-11-01T15:14:50.000Z"bf41cf6fd9ca8ca9cca8fe28e009c4b1"1085465STANDARDpdf/programs/report484.pdf2011-11-01T15:14:50.000Z"feb36a06b1f72686b5115589a6624e3a"330618STANDARDpdf/programs/report485.pdf2011-11-01T15:14:50.000Z"678a05d7576bc18db57ffbacfa671840"444843STANDARDpdf/programs/report486.pdf2011-11-01T15:14:51.000Z"4ea30000c8cfe7ad912374d57937b798"552236STANDARDpdf/programs/report487.pdf2011-11-01T15:14:51.000Z"1decce037f70460fb485945acb0a4f95"669756STANDARDpdf/programs/report489.pdf2011-11-01T15:14:51.000Z"c95df70419e633403ea488bb19a94d59"572727STANDARDpdf/programs/report490.pdf2011-11-01T15:14:51.000Z"55bc89224f5c56b5ed50158d6f34007e"643186STANDARDpdf/programs/report491.pdf2011-11-01T15:14:52.000Z"07b143a758482d8e958cb668242f7460"534089STANDARDpdf/programs/report494.pdf2011-11-01T15:14:52.000Z"222e092be790a8f2a2a7cafbd490faca"1018658STANDARDpdf/programs/report496.pdf2011-11-01T15:14:52.000Z"908a5fd1f38c0e4723e53324b597f076"58856STANDARDpdf/programs/report497.pdf2011-11-01T15:14:52.000Z"59cfbb05e0e4ae9574ea48834beaa0a9"181600STANDARDpdf/programs/report498.pdf2011-11-01T15:14:53.000Z"dab15f2923217a1f5c99ee065d95f216"1087131STANDARDpdf/programs/report500.pdf2011-11-01T15:14:53.000Z"da5f00d909bf1e784ea3fda0d57dbb1d"88347STANDARDpdf/programs/report501.pdf2011-11-01T15:14:53.000Z"085868f18b90ce8a762505d61b467fe3"1326395STANDARDpdf/programs/report502.pdf2011-11-01T15:14:54.000Z"e63a27dcb0c97133f0dbca20acf3a1c7"1108978STANDARDpdf/programs/report503.pdf2011-11-01T15:14:54.000Z"570b552f8fec1c380c29b7263f15338e"76804STANDARDpdf/programs/report504.pdf2011-11-01T15:14:54.000Z"d99ddb0db01205f55c02ec5f855de72b"270969STANDARDpdf/programs/report506.pdf2011-11-01T15:14:54.000Z"9814b89a574d32e45cd2f1c735047797"946764STANDARDpdf/programs/report509.pdf2011-11-01T15:14:55.000Z"906b582b6912b281a1efe9d7dc4a7471"53438STANDARDpdf/programs/report510.pdf2011-11-01T15:14:55.000Z"1746e00ce0a9070cea063f054ecd0cce"348449STANDARDpdf/programs/report511.pdf2011-11-01T15:14:55.000Z"744e6e00665fe61e4cc4e1fd90df5852"1504367STANDARDpdf/programs/report512.pdf2011-11-01T15:14:55.000Z"d99ddb0db01205f55c02ec5f855de72b"270969STANDARDpdf/programs/report513.pdf2011-11-01T15:14:56.000Z"b435ed2cda2b97637224fcb2900eb532"63904STANDARDpdf/programs/report516.pdf2011-11-01T15:14:56.000Z"085868f18b90ce8a762505d61b467fe3"1326395STANDARDpdf/programs/report518.pdf2011-11-01T15:14:56.000Z"0128c07d003e08c2f40febcfd2e6278f"1230937STANDARDpdf/programs/report519.pdf2011-11-01T15:14:57.000Z"cd2de414b4c11dd8eb38c9aa3d423e02"468819STANDARDpdf/programs/report520.pdf2011-11-01T15:14:57.000Z"293e444b693496ad4b67d608a79c073a"979798STANDARDpdf/programs/report521.pdf2011-11-01T15:14:57.000Z"9814b89a574d32e45cd2f1c735047797"946764STANDARDpdf/programs/report522.pdf2011-11-01T15:14:58.000Z"ad6b453405a953f26c65fc9a077ff44c"93167STANDARDpdf/programs/report523.pdf2011-11-01T15:14:58.000Z"1ec9fc1ba39e0ab2e357d5b1dfe30479"260105STANDARDpdf/programs/report525.pdf2011-11-01T15:14:58.000Z"31c24ce790d09abc24ded272ddb5cfbd"589078STANDARDpdf/programs/report527.pdf2011-11-01T15:14:58.000Z"7705035a440a0da3f8d50960f9fa3a3e"423244STANDARDpdf/programs/report528.pdf2011-11-01T15:14:58.000Z"0c218cfa99649f07af5b087a4f0eb93f"1435533STANDARDpdf/programs/report529.pdf2011-11-01T15:14:59.000Z"ad6b453405a953f26c65fc9a077ff44c"93167STANDARDpdf/programs/report530.pdf2011-11-01T15:14:59.000Z"1ec9fc1ba39e0ab2e357d5b1dfe30479"260105STANDARDpdf/programs/report531.pdf2011-11-01T15:14:59.000Z"eadfb5c755d734bf71076167f9c17702"486980STANDARDpdf/programs/report532.pdf2011-11-01T15:14:59.000Z"da5f00d909bf1e784ea3fda0d57dbb1d"88347STANDARDpdf/programs/report533.pdf2011-11-01T15:14:59.000Z"f0e3274467a32776886ae1ce10c45471"292345STANDARDpdf/programs/report534.pdf2011-11-01T15:15:00.000Z"f0e3274467a32776886ae1ce10c45471"292345STANDARDpdf/programs/report535.pdf2011-11-01T15:15:00.000Z"1ffe7648a7ab27c6fddd9173444c14dd"812373STANDARDpdf/programs/report537.pdf2011-11-01T15:15:00.000Z"4a546ffb3a369e300b60b4dde1fb90e0"1288052STANDARDpdf/programs/report539.pdf2011-11-01T15:15:01.000Z"293e444b693496ad4b67d608a79c073a"979798STANDARDpdf/programs/report544.pdf2011-11-01T15:15:01.000Z"61ceac3391d72eb3e3a8a8b04ad7bb18"965183STANDARDpdf/programs/report545.pdf2011-11-01T15:15:01.000Z"ea5cfcd8de5ee64678f65e9e1786cc27"1368779STANDARDpdf/programs/report548.pdf2011-11-01T15:15:02.000Z"cfd80bb9ee58374ebc354215332bec0a"952150STANDARDpdf/programs/report549.pdf2011-11-01T15:15:02.000Z"2cff37cbec8032cefba8c3b31155233b"591332STANDARDpdf/programs/report550.pdf2011-11-01T15:15:02.000Z"1b9a8332fd1a709dc04b38ceeff8c36d"584381STANDARDpdf/programs/report552.pdf2011-11-01T15:15:03.000Z"46eb63e9de23dab64ff2133276d26511"1282086STANDARDpdf/programs/report554.pdf2011-11-01T15:15:03.000Z"6afabcd506eed99a89329cab3e8f91e6"628853STANDARDpdf/programs/report555.pdf2011-11-01T15:15:04.000Z"4c54075856b23765c8c8d4d1ab0dff0c"744848STANDARDpdf/programs/report558.pdf2011-11-01T15:15:04.000Z"08ad9b73ecf310f3e8a070b6e1f1f77a"793747STANDARDpdf/programs/report561.pdf2011-11-01T15:15:04.000Z"ea5cfcd8de5ee64678f65e9e1786cc27"1368779STANDARDpdf/programs/report563.pdf2011-11-01T15:15:05.000Z"d3d0c1ab12973a24c7ea6890d9ddb3c7"499159STANDARDpdf/programs/report564.pdf2011-11-01T15:15:05.000Z"07a00ae7aef7c48d30b1bd824bbcfa35"515202STANDARDpdf/programs/report566.pdf2011-11-01T15:15:05.000Z"da2b90cc34346c92fb48a988e132bca6"773484STANDARDpdf/programs/report567.pdf2011-11-01T15:15:06.000Z"41941ed5453b650039358f42270c87b1"1498483STANDARDpdf/programs/report569.pdf2011-11-01T15:15:06.000Z"cfd80bb9ee58374ebc354215332bec0a"952150STANDARDpdf/programs/report570.pdf2011-11-01T15:15:06.000Z"8f273df421e9f07679f1d5f89f6f4da3"530222STANDARDpdf/programs/report571.pdf2011-11-01T15:15:07.000Z"bee7b1078a57197ee7cd786e5fdfb7cc"570894STANDARDpdf/programs/report572.pdf2011-11-01T15:15:07.000Z"9ba25967e0102e7ab74861c96cf67738"503053STANDARDpdf/programs/report574.pdf2011-11-01T15:15:07.000Z"eadb40b2b1ebd8f92ce246355cc81951"440279STANDARDpdf/programs/report578.pdf2011-11-01T15:15:07.000Z"a82ab5de04c153e8549e69ea9ac16e97"519579STANDARD